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Title Enhancing the efficacy of antimicrobial peptide BM2, against mono-species biofilms, by 
combining with detergents. 
Aim To investigate if a detergent regime could enhance the antimicrobial ability of BM2. 
Method Strains of Enterococcus faecalis, Streptococcus gordonii, Streptococcus mutans, and 
Candida albicans were grown from glycerol stocks after confirmation of the strains. After 
subculturing single colonies were cultured in TSB and CSM liquid media for 24hr to obtain a 
microbial suspension which was adjusted to OD600nm = 0.5. 
Dilution series of the peptidomimetic BM2 and detergents were prepared in aqueous solution and 
minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were 
determined using a broth micro-dilution method. 
Further on planktonic cells and monospecies biofilms were exposed to the detergent and BM2 
combinations. The efficacy of BM2 and detergents at causing biofilm detachment was measured 
using a crystal violet based assay. 
Results Planktonic cells were easier to kill with some of the detergents in isolation or in 
combination with BM2. SDS and CTAB in combination with BM2 increased the efficacy of BM2 
against the test organisms. Tween 20 did not kill any of the test organisms alone or in combination. 
Biofilms were harder to eradicate and detergent, BM2 combinations gave varied results for the 
different species tested. Detergents in combination with BM2 did not increase the efficacy of the 
antimicrobial peptide in disrupting S. mutans biofilm.  
SDS in combination with BM2 did not increase the efficacy of the antimicrobial peptide in 
disrupting E. faecalis biofilm at the 24 and 48 hr periods however at the 72 hr period there was 
disruption of biofilm. CTAB in combination with BM2 did not increase the efficacy of the 
antimicrobial peptide in disrupting E. faecalis biofilm. 
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CTAB in combination with BM2 increased the efficacy of the antimicrobial peptide in disrupting 
S. gordonii biofilm at the 24 hr period, however at the 48 and 72 hr no disruption was noted. SDS 
in combination with BM2 did not increase the efficacy of the antimicrobial peptide in disrupting 
S. gordonii biofilm. 
CTAB in combination with BM2 increased the efficacy of the antimicrobial peptide in disrupting 
C. albicans biofilm at the 24 hr period, however at the 48 and 72 hr no disruption was noted. SDS 
in combination with BM2 increased the efficacy of the antimicrobial peptide in disrupting C. 
albicans biofilm at the 24 and 48 hr periods, however at the 72 hr period, the combination did not 
disrupt C. albicans biofilm. 
Conclusion Within the limits of this in-vitro study a combination of BM2 and SDS showed 
antimicrobial action against certain endodontic microorganisms occurring as planktonic cells and 
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Chapter 1  Introduction 
Root canal therapy has a long history in dentistry as a treatment option for the management of pulp 
and periapical disease. The success rate has tremendously increased over the years owing to various 
advancements in clinical practice and better understanding of the aetiology of pulp and periapical 
disease. The major aetiologic agent of periapical disease is microorganisms (Siqueira 2008). 
Although various chemical and physical factors can induce periradicular inflammation, evidence 
clearly indicates that microorganisms are essential for the establishment and progression of 
different forms of pulp and periapical disease (Kakehashi et al. 1965)  
More than 1000 bacterial species can be found in the oral cavity, with any particular individual 
harbouring 100-200 of these species (Paster et al. 2006, Keijser et al. 2008, Paster & Dewhirst 
2009). Endodontic infections are polymicrobial in nature and bacteria exist as biofilms. In primary 
root canal infections obligate anaerobic bacteria dominate while various other microorganisms are 
related to intraradicular and extraradicular infections and persistent infections.  
Since microorganisms play a key role in pulp and periapical disease progression, (Kakehashi et al. 
1965, Möller et al. 1981) elimination of microbes within the root canal system and radicular dentine 
is crucial for successful endodontic therapy (Byström & Sundqvist 1983, 1985, Shuping et al. 
2000).This is achieved by chemo-mechanical root canal preparation. While these techniques can 
drastically reduce the microbial load, elimination of microbes may be incomplete (Byström & 
Sundqvist 1981, 1983, 1985, Shuping et al. 2000). Consequently, the use of an intracanal 
medication has been recommended as an adjunct to eliminate residual microorganisms harboured 
in the complexities of the root canal system and radicular dentinal tubules (Nair et al. 1990, Sjögren 
et al. 1991) . 
Current intraradicular medicaments have the disadvantage of toxicity to host tissues or poor 
bactericidal effect. The development of an antimicrobial agent with low host toxicity and effective 
reduction or elimination of the microbial load in biofilms would be advantageous. Numerous 
polypeptides has been found to act as potential antimicrobials in the laboratory study 
(Komatsuzawa et al. 2007, Tong et al. 2010). Antimicrobial peptides (AMPs) are polypeptides 
expressed by many life forms in host defence settings. Several have been found to have a broad 
spectrum antimicrobial activity against microorganisms, including viruses, mycoplasma, fungi, and 
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bacteria and (AMPs)  surface charge results in low toxicity to host tissues (Brogden 2005, Klotman 
& Chang 2006, Aerts et al. 2008). Antimicrobial activity against bacteria and fungi is of particular 
interest to the field of endodontics because of the contribution of these microbes in the aetiology 
of pulp and periapical disease. 
Research in the laboratory of Associate Professor Monk at the University of Otago School of 
Dentistry discovered the synthetic peptide D-decapeptide BM2 (Monk et al. 2005). This peptide 
was found to have microbicidal activity against planktonic cultures and biofilms of endodontic 
pathogens, including the significant endodontic pathogen E. faecalis, at concentrations several 
hundred-fold lower than the endodontic irrigant Sodium Hypochlorite (Yoganathan 2012) and the 
intraradicular medicament Calcium Hydroxide (Othman 2014). Work with other short chain 
peptides has shown promise in limiting the growth of bacteria and the fungal pathogen Candida 
albicans (Love 2012) and invasion of dentine (Love, unpublished results).  
This thesis will examine means to enhance the effectiveness of antimicrobial peptide BM2 aiming 





Chapter 2 Literature Review 
2.1 Biofilms 
2.1.1 History of biofilms 
Biofilms are ubiquitous in normal and pathogenic human processes and are essential for host 
development and health (Dufour et al. 2012). Historically it was assumed that microorganisms 
lived in isolation without interacting. However it has been proven that microorganisms 
predominantly live in dense biofilm populations interacting extensively with each other (Nadell et 
al. 2008).  
Antonie van Leewenhoek (1632-1723), a Dutch microscopist was the first to observe bacteria and 
protozoa with his primitive microscope. He called them “very little animalcules,” which he isolated 
from different sources, such as rainwater, pond/well water, and the human mouth and intestine. He 
scrapped his teeth and observed the presence of animalcules (Marsh & Bradshaw 1995). He then 
tried to clean his teeth by prolonged rinsing with strong wine-vinegar and failed to remove this 
plaque layer (Guggenheim & Schmid 1989). This became the first documented evidence of, the 
presence of bacteria in the oral cavity and the study of dental plaque. However, it was not until late 
1970’s that biologists began to appreciate that bacteria live in surface attached sessile communities 
called biofilms (Costerton et al. 1978).  
Biofilms are defined as “matrix-enclosed bacterial communities’ adherent to each other and/or to 
surfaces or interfaces” (Costerton et al. 1994), which enables them to exhibit a wide range of 
physical, metabolic and molecular interactions (Donlan & Costerton 2002, Marsh 2004). These 
interactions are important for the attachment, growth and survival of the species. These co-
ordinated, spatially organized, and metabolically integrated communities can develop on virtually 
every natural and man-made surface. Biofilm formation has been shown for numerous 
microorganisms and is one of the main strategies for their survival in their niches (Wolcott & 
Ehrlich 2010). In natural habitats, biofilms provide mechanisms to allow homeostasis of the host 
(Hall-Stoodley et al. 2004).  
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2.1.2 Characteristics of biofilms 
Biofilms provide a protected mode of growth which allows cell survival by withstanding hostile 
environments and hence presents a challenge for treating chronic biofilm infections (Davies 2003, 
del Pozo & Patel 2007). Microorganisms which present in chronic infections as biofilms resist host 
immune responses and antibiotic treatment which makes them harder to eradicate (Dufour et al. 
2012).  
Caldwell et al. (1997) emphasized four characteristics of a biofilm: 
 Autopoiesis: The ability to self-organize 
 Homeostasis: Resistance to environmental perturbations 
 Synergy: Improved efficiency through synergistic relationships 
 Communality: Responds to environmental changes as a unit rather than as individuals. 
2.1.3 Composition and formation of biofilm 
Biofilms are a complex biological system that are structurally and dynamically organized. The 
microorganisms within the system are strategically placed for optimal metabolic interaction hence 
the resultant architecture favours the physiology and ecological role of the system. The properties 
displayed by a multispecies biofilm are due to the interactions between the different 
microorganisms within the layers. These properties can be very unique to the system and if the 
organisms are isolated these functions would not be observed. Therefore it can be stated that 
biofilms behave in a complex way that is rather similar to multi-cellular organisms (Nadell et al. 
2009, Hall-Stoodley 2004). Hence the development of biofilms can be described as a dynamic 
process involving many complex stages that require interaction between microorganisms and 
between microorganism and the host. Understanding these interactions might help in the 
development of effective antimicrobial strategies.  
Bacteria can form biofilms on any surface in an environment that is able to provide nutrients. This 
usually involves interactions between bacterial cells, a solid surface, and a fluid medium (Costerton 
et al.1987). A summary of oral biofilm development follows with a diagrammatic representation 
on a tooth surface in Figure 2.1. 
5 
 
2.1.4 Adhesion to tooth surfaces 
Biofilm formation begins with planktonic cells within an aqueous environment attaching initially 
to a selected abiotic or biotic surface (Gilbert et al. 1997). Attachment is usually on a conditioning 
film normally made of organic molecules (e.g. nutrients, salivary proteins, large macromolecules) 
that can promote adherence of the microorganisms to the selected surface (Dufour et al. 2012). 
Depending on the site and type of surface the biofilm differs.  
Initially attachment is by weak reversible van der Waals forces between the cell surface and 
substratum, which can later lead to stronger adhesion receptor mediated attachment (Donlan 2002). 
Dipole, hydrogen, ionic, or hydrophobic irreversible interactions can occur through participation 
of bacterial cell surface structures such as flagella, fimbriae, LPS, and exopolysaccharides (Dufour 
et al. 2012). For example Streptococci which are primary oral colonisers, bind to surface receptors 
using a complex protein pellicle which is derived from saliva, serum and dentinal fluid (Love 
2002). 
2.1.5 Co-aggregation 
Once the primary colonizers attach to the surface they change the environment and provide 
additional binding sites to other bacteria that cannot bind directly to the surface. This stage is known 
as co-aggregation (Svensater & Bergenholtz 2004), which allows other organisms to join the 
community and contribute to its development (Branda et al. 2005).  
2.1.6 Metabolism 
As co-aggregation proceeds the biofilm’s nutritional needs become more complex. Nutrition is 
provided by substrates such as food consumed by the host, saliva, gingival crevicular fluid, host 
tissues such as pulp and other micro-organisms, such as the breakdown products from one micro-
organism can be a source of nutrient for another (Kolenbrander et al. 2002). Certain bacteria obtain 
specific substrates from others for proliferation (Carlsson et al. 1984, Love 2007). Interestingly, 
biofilms are very complex and heterogeneous with characteristics that are highly diverse. Even in 
mono-species biofilm, phenotypic heterogeneity exists, with cells of the species exhibiting 
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different phenotypes in a biofilm even though they are separated by as little as 10 µm (Socransky 
& Haffajee 2000, Dufour et al. 2012). 
2.1.7 Inhibitory substances and metabolites 
As biofilms growth progresses both useful metabolic by-products and inhibitory substances, such 
as bacteriocins are produced. These help the community regulate the population within the system 
and this phenomenon of quorum sensing plays a huge impact in shaping the biofilm community 
(Svensater & Bergenholtz 2004). 
2.1.8 Extracellular polymeric substance (EPS) 
The molecular mechanisms that regulate the developmental steps in biofilm formation differ 
between different bacterial species, and also depend on environmental conditions (Dufour et al. 
2012). Nonetheless biofilms exhibit one common characteristic, the biofilm matrix known as the 
extracellular polymeric substance (EPS). 
Biofilm cells are embedded in this self-produced extracellular matrix, which has a primary function 
to hold cells together (Flemming & Wingender 2010). EPS may vary in chemical and physical 
properties, but its major components are polysaccharides (homo- and heteropolysaccharides), 
proteins, nucleic acids, lipids and extracellular DNA (Costerton 2007). 
Biofilms are made up of about 80–85% EPS (by volume) and only 15–20% cells (by volume) 
(Kokare et al. 2009). EPS plays a major role in maintaining the integrity of the biofilm through the 
functions as stated below (Sutherland 2001, Donlan 2002, Flemming & Wingender 2010, Dufour 
et al. 2012): 
 Adhesion: Initiation of colonisation of micro-organisms onto abiotic and biotic surfaces 
and the long-term attachment of the biofilms. 
 Aggregation: Enables gathering of cells by bridging and temporary immobilization of 
bacterial populations, for the development of high cell densities and cell-cell recognition. 
 Cohesion: Mediates the mechanical stability of biofilms, determines its architecture, also 
allows cell-cell communication.  
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 Retention of water: Maintains a highly hydrated micro-environment hence, providing 
tolerance of biofilms to desiccation in water-deficient environments. 
 Protective barrier: Provides resistance to nonspecific and specific host defences, and 
tolerance to various antimicrobial agents (disinfectants and antibiotics). 
 Sorption of organic compounds: Enables accumulation of nutrients from the environment 
and the sorption of xenobiotics. 
 Sorption of inorganic ions: Promotes polysaccharide gel formation, ion exchange, mineral 
formation and the accumulation of toxic metal ions. 
 Enzymatic activity: Helps in digestion of exogenous macromolecules for nutrients and the 
degradation of structural EPS, therefore allowing the release of cells. 
 Nutrient source: Provides a source of carbon, nitrogen and phosphorus-containing 
compounds. 
 Exchange of genetic information: Facilitates gene transfer between cells.  
 Electron donor or acceptor: Allows redox activity in the biofilm. 
 Export of cell components: Enables release of cellular material as a result of metabolic 
turnover. 
 Sink for excess energy: Stores excess carbon. 
 Binding of enzymes: Enables accumulation, retention and stabilization of enzymes through 




Figure 2.1: Diagrammatic representation of the sequence of adherence and colonisation of tooth 
surfaces by bacteria. (A) Primary colonising bacteria existing as planktonic cells interact with the 
conditioning film (e.g. acquired pellicle, dentinal tubule fluid, serum) on the tooth surface using 
longer-range interactions (e.g. pili) or shorter-range molecular interactions. (B) The early 
colonisers form strong bonds with the surface molecules in the conditioning film or components of 
the tooth substrate (e.g. collagen) by a variety of mechanisms and multiple adhesins. In conjunction 
with adhesion, the bacteria perform other functions such as adapting to the available nutrition, 
inter-microbial signalling, and production of an extracellular matrix. (C) Late colonising bacteria 
enter the community by co-aggregation reactions, contributing to sequential binding and 
colonisation of the developing biofilm. In this regard, Fusobacterium has been shown to be an 
important bridging organism, allowing interactions between non-binding bacteria. Within the 
biofilm, intricate processes and interactions such as quorum sensing, metabolic communication, 
genetic exchange, and competitive interactions further shape the membership of the complex 
community, ensuring efficient utilization of nutrients and reduced susceptibility to host defences 
or therapeutic methods (e.g. antimicrobials). (Adopted with approval from Love 2010). 
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2.1.9 Advantages of biofilms 
Living in a biofilm offers several advantages to the micro-organisms within the system (Costerton 
et al. 1987, Costerton et al. 1995, Socransky & Haffajee 2000, Donlan & Costerton 2002, Stoodley 
et al. 2002, Marsh 2003, 2005, Hall-Stoodley et al. 2004). They are as follows:  
 The creation of broader habitat range for the growth of a more diverse microbiota. 
 Increased metabolic diversity and efficiency. 
 Protection (competing micro-organisms, host defences, antimicrobial agents, and 
environmental stresses). 
 Facilitated cell–cell communication (quorum sensing). 
 Facilitated genetic exchanges.  
 Enhanced pathogenicity, due to synergism. 
2.1.10 Biofilms in dentistry 
The oral cavity offers a hospitable ecosystem for many micro-organisms. This ecosystem is warm 
and moist, nutrient-rich, constantly washed with saliva, and has a pH of between 6.75 and 7.25. 
The presence of micro-organisms is critical in retaining the normal physiology of the oral cavity 
(Marsh 2005). This relationship in this ecosystem is usually stable and reciprocally favourable, 
however if some external force changes the balance, the result can be dental disease (Marsh 2000). 
Dental plaque is a diverse microbial community found on the tooth or other hard surfaces in the 
oral cavity embedded in a matrix of polymers of bacterial and salivary origin (Marsh 2005, Marsh 
& Martin 2009). Dental plaque is one of the most studied biofilms due to its relative availability 
for sampling and convenient microbial culture and analysis, (Marsh 2005, 2009, Marsh et al. 2011). 
The composition of plaque varies at different sites over the tooth surfaces due to differences in the 
local biological properties. The bacterial cells are roughly 15-20% by volume, while EPS 
(glycocalyx) constitutes around 70-80% of biofilm. In addition to microbes an oral biofilm consists 
of organic (carbohydrates, proteins, and lipids) (Richards et al. 1999, Katsikogianni & Missirlis 
2004) and inorganic substances (calcium, phosphorus, magnesium, and fluoride). More than 1000 
different bacterial species have been identified in the oral cavity by culture and independent 
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molecular microbiology, however advanced techniques may show that the number may be higher 
(Keijser et al. 2008, Paster & Dewhirst 2009). Formation of an oral biofilm involves;  
I. Pellicle formation (conditioning substance),  
II. Bacterial colonisation, and  
III. Biofilm maturation. 
I. Pellicle formation (conditioning substance): The first phase is the formation of a conditioning 
film (the acquired pellicle) on the tooth surface, which occurs within seconds after the tooth surface, 
is cleaned. The pellicle consists of glycoproteins (mucins), proline-rich proteins, amylase 
(enzymes) and other molecules that serve as attachment sites for bacteria (Marsh et al. 2011). 
Bacterial colonisation: The second phase is the initial adhesion and attachment of bacteria. It is a 
non-specific reversible phase that involves physicochemical interactions between salivary bacteria 
and the acquired enamel pellicle (Marsh & Bradshaw 1995). This is mediated by short-range 
specific stereo-chemical molecular interactions (van der Walls & electrostatic forces) between 
primary bacterial colonisers and host receptor molecules in the acquired pellicle (Costerton et al. 
1995). After initial adhesion, a firm attachment is established to already attached primary 
colonisers (co-aggregation) 
Biofilm maturation: The third phase is colonisation and plaque maturation (Marsh & Bradshaw 
1995). This occurs when primary attached bacteria provide new surfaces for attachment of new 
bacteria called ‘co-adhesion’. The aggregated bacteria start growing, resulting in the formation of 
microcolonies and the development of mature biofilm. 
In the oral environment oral biofilm can become calcified and is then known as calculus. Calculus 
is formed by precipitation of calcium phosphates within the organic dental plaque matrix. However, 
it depends on several factors such as plaque pH, local saturation of calcium and phosphate, and 
availability of fluoride ions and biological factors such as crystallization nucleators/inhibitors from 




An oral biofilm is very diverse and several factors contribute to its development, such as abundance 
of nutrients, moisture, hospitable temperature, host defence mechanisms and the availability of 
different surfaces (e.g. tongue, epithelial cells, enamel) (Dufour et al. 2012). 
 
Figure 2.2: Dental plaque biofilm. The pellicle and biofilm extracellular matrix are illustrated as 
firmly inserted in each other contributing to the well-known recalcitrant nature of dental plaque. 
The large arrows show solvent flow that occurs through both large and small aqueous channels that 
are believed to carry nutrients and metabolic products to different members within the community 
(Adopted with approval from Darveau et al. 1997) 
2.1.11 Biofilms in endodontics 
Bacteria in root canals exist as biofilms as in other bacteria-associated dental diseases such as dental 
caries and periodontal disease (Siqueira & Rôças 2009). The diversity of the endodontic microbiota 
has been unravelled by studies first using advanced anaerobic culture techniques (Sundqvist 1992) 
and then sophisticated molecular microbiology methods (Siqueira et al 2011, Jhajharia et al. 2015). 
These studies have demonstrated more than 400 different microbial species concluding that 
endodontic infections are invariably caused by biofilms whose diversity may vary according to the 
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type of infection and clinical manifestation of the disease (Siqueira & Rôças 2009). Endodontic 
bacteria fall into 15 phyla, and in root canals the most commonly occurring species belong to the 
phyla Firmicutes, Bacteroidetes, Actinobacteria, Fusobacteria, Proteobacteria, Spirochaetes, and 
Synergistes (Munson et al. 2002, Siqueira Jr & Rôças 2005b, Saito et al. 2006, Jhajharia et al. 
2015). Additionally a different range of micro-organisms has been found in primary infections 
compared to in secondary/persistent infections (Siqueira Jr & Rôças 2005a).  
The literature on initial infections within the root canal system reports dominance by facultative 
anaerobes. However, with time the relative proportion of obligate anaerobic species increases and 
overtakes the earlier colonizers (Fabricius et al. 1982a). Initiation of dentine infection and invasion 
are thought to be by Gram positive bacteria that are prominent in dental plaque (Streptococcus and 
Actinomyces species) (Love 2004). The microbial composition shifts as infection progresses, to 
dominance by obligate anaerobes (Fusobacterium, Porphyromonas, Prevotella, Eubacterium, and 
Peptostreptococcus species) (Love 2004) in an established asymptomatic infected root canal 
system. For intact teeth with necrotic pulps Sundqvist et al. (1989) reported strict anaerobes made 
up more than 90% of the bacteria in such root canal systems. Limitations  from the root canal 
systems and periapical tissues, forms a unique assortment of micro-organisms within the root 
canals ecosystem (Sundqvist 1992b). Studies have confirmed that teeth with refractory endodontic 
disease have a different microbial composition to primary infections. Teeth with refractory 
endodontic disease are thought to have reduced microbial load and predominance of microbes from 
the Enterococcus, Streptococccus and Candida species (Siqueira & Rocas 2004). 
2.1.12 Endodontic biofilm classification and formation 
Endodontic bacterial biofilms can be classified as (Jhajharia et al. 2015): 
 Intracanal biofilms 
 Extraradicular biofilms 
 Periapical biofilms 
 Biomaterial-centered infections. 
Endodontic biofilm formation does not follow the same process as other biofilms. The dynamics 
of endodontic biofilm formation has been thought to be different and a theory has been suggested 
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by Siqueira et al. (2012) that endodontic biofilm formation is different in the sense that initial 
colonisation of a solid surface by planktonic micro-organisms floating in a fluid phase that bathes 
that surface does not happen. On the contrary caries acts as the biofilm reservoir and hence, when 
the dentine layer is destroyed, the pulp becomes exposed to the caries biofilm (and planktonic 
micro-organisms floating in saliva). As a result, the pulp becomes severely inflamed, and or 
necrotic as the biofilm advances in an apical direction. Therefore it is assumed that the process of 
biofilm formation in endodontic infections occurs gradually in the canal as the process migrates in 
an apical direction. 
At the advancing front of a root canal infection, the biofilm enters into contact with the host tissue, 
which is inflamed containing large amounts of inflammatory exudate, that serve as an optimal 
source of nutrients for the advancing biofilm (Langeland 1987). 
The primary colonizers in primary intraradicular infections are bacterial species found in biofilms 
from deep dentinal caries (Hoshino 1985, Munson et al. 2004, Chhour et al. 2005, Aas et al. 2008, 
Lima et al. 2011). It has been hypothesised that as the biofilm advances apically newer species 
may join the biofilm from saliva provided they are competitively competent and bring ecological 
advantages to the overall community physiology (Siqueira et al. 2012). 
With time, the biofilm structure becomes organized and reaches a state of homeostasis which is 
known as a ‘climax community’. Once a climax community is established, the composition of the 
biofilm community is expected to remain stable, unless the environment changes. The removal of 
this climax community has been an aim for researchers as the complex anatomy of the root canal 
system makes it hard for the management strategies to reach these communities of bacteria and 
destroy them. 
2.1.13 Management strategies for biofilms within the root canals 
The effective management of any disease requires the clinician to direct treatment towards 
removing the aetiological factor. To achieve this goal, two major management strategies has been 




Chemo-mechanical preparation includes mechanical instrumentation and use of a chemical irrigant 
to enhance soft tissue and microorganism eradication. Gomes et al. (1996b) have shown that 
despite great reduction in biofilms, survival of bacteria can still occur and between appointments 
may multiply. Byström and Sundqvist (1981, 1983, 1985) in their classical studies have shown 
bacterial survival after teeth had been treated with mechanical instrumentation with hand-files and 
Sodium Hypochlorite as an antimicrobial irrigant. However Byström et al. (1985b) showed that 
Calcium Hydroxide, as an intracanal medicament eliminated surviving bacteria within the root 
canals in their study of single rooted teeth with apical periodontitis.  
The ideal properties of an intracanal medicament has been highlighted as (Martin 1979): 
 having a wide and prolonged antimicrobial spectrum in order to eliminate the polymicrobial 
biofilm,  
 non-irritating to the periapical tissues, 
 being stable in solution,  
 being easily introduced and removed from the canal  
 being in a form that is able to penetrate the dentinal tubules and  
 being non-staining to the tooth tissue. 
The major reason for the use of intracanal medicaments is to eliminate or reduce micro-organisms 
remaining after chemo-mechanical preparation. Other purposes are to reduce inflammation of the 
periapical tissues and remnants of the pulp, prevent or reduce post-operative pain, render the canal 
contents inert, help to dry persistently wet canals, promote healing of calcified tissues and control 
root resorption (Walton 1984, Chong & Ford 1992).  
Currently there is no ideal intracanal medicament that can fulfil all the attributes as above hence, 
numerous products has been tried and test. The two major medicaments that are frequently utilised 
are Calcium Hydroxide and antibiotic based corticosteroid paste e.g. Ledermix paste (Sigma 
Pharmaceuticals Pty Ltd, Victoria, Australia). 
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2.1.14 Root canal medications  
2.1.14.1 Calcium Hydroxide 
Calcium Hydroxide is the most commonly used intracanal medicament (Byström et al 1985b) and 
was introduced by Hermann in 1920. Initially it was utilised as a vital pulp therapy agent until its 
utilization as a medicament in 1970s (Heithersay 1975). It is a white odourless powder available in 
many different forms, mixed in various vehicles and commercial products (Fava & Saunders 1999). 
The main mechanism of action is due to its high pH of approximately 12.5. In an aqueous 
environment Calcium Hydroxide dissociates into calcium and hydroxyl ions. The hydroxyl ions 
damage the bacterial cell membranes, react with bacterial DNA inhibiting its replication, and result 
in the denaturation of proteins. Most pathogens associated with pulp and periapical disease are 
unable to survive this highly alkaline environment (Heithersay 1975, Byström et al. 1985b) 
However, to reduce the bacterial load sufficiently; hydroxyl ions must be able to diffuse into the 
dentinal tubules at adequate concentrations. The concentration in tubules is affected by tubule 
diameter and density and also dentine has the capacity to buffer the hydroxyl ions by the presence 
of hydroxyapatite (Wang and Hume 1988). A diffusion dynamic study by Nerwich et al. (1993) 
found that calcium Hydroxide diffused into the inner radicular dentinal tubules within a few hours 
but took up to 7 days to reach the outer tubules. The rate of diffusion was different in the apical as 
compared to the cervical area due to dentine permeability being different in these areas. Despite its 
noteworthy bactericidal effects against most endodontic pathogens, its ineffectiveness at 
eliminating E. faecalis (Byström et al. 1985, Ørstavik & Haapasalo 1990, Safavi et al. 1990, Evans 
et al. 2002) and C. albicans (Waltimo et al. 1999) directs one to other intracanal medicament 
choices. 
2.1.14.2 Ledermix paste 
Ledermix paste is another medicament occasionally utilised in root canal treatment. Its major 
components are 1% triamcinolone acetonide (corticosteroid) and 3% demeclocycline (antibiotic). 
The main indications for its use as an intracanal medicament are in cases of severe inflammation 
of the pulp, for pain relief (Ehrmann 1965, Ehrmann et al. 2003), for inflammatory root resorption 
(Pierce & Lindskog 1987), and as an antibacterial agent (Taylor et al. 1989). 
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The major drawback of this medicament is the discolouration associated with its use (Kim et al. 
2000) which has been attributed to tetracycline. Kim et al. (2000) in his study has highlighted the 
issues surrounding the use of Ledermix paste, specifically the discolouration associated with its 
use (Kim et al. 2000).  
2.1.14.3 Odontopaste  
Odontopaste is another antibiotic based corticosteroid paste. It is a zinc oxide-based paste with 5% 
clindamycin hydrochloride, 1% triamcinolone and 0.5% calcium Hydroxide for the preservation of 
the steroid component (Athanassiadis et al. 2011). It has been advertised by manufacturers to have 
similar anti-inflammatory effects to Ledermix however with no discoloration of the tooth structure. 
However a study by Lal et al. 2013 showed yellowish discoloration of tooth with utilization of 
Odontopaste, which might clinically be harder to bleach. 
2.1.14.4 Peptides  
Nisin is a class I antimicrobial peptide which was introduced in 1951 as a food preservative (Hirsch 
1951). Its antimicrobial activity is by pore formation on microbial walls and inhibition of cell wall 
synthesis (Turner et al. 2004, Bonelli et al. 2006, Field et al. 2010).  
Nisin was first utilised against root canal system pathogens by using it with MTAD, a root canal 
irrigation solution, (Tong et al. 2012) where it enhanced the antibacterial activity of MTAD. 
Another peptide which has been shown to have effects on endodontic pathogens is, human β 
defensin 3 (HBD3).  It has potent antimicrobial activities at low concentration against both gram 
positive and gram negative bacteria when compared with HBD1 and HBD2 (Zhao et al. 1996, 
Dunsche et al. 2002). Further studies by Feng et al. (2005) found that recombinant HBD3 was 
effective in killing most C. albicans species at low micromolar concentrations while Lee et al, 
(2013) showed HBD3 was more effective against 3 weeks old E. faecalis biofilms compared to 
aqueous Calcium Hydroxide paste and 2% Chlorhexidine gel in a laboratory based study. 
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2.2 Antimicrobial peptides (AMPs) 
Antimicrobial peptides (AMPs) are small molecular weight proteins with broad spectrum 
antimicrobial activity found in all living species (Hancock & Diamond 2000, Izadpanah & Gallo 
2005). These diverse group of molecules can be divided into subgroups on the basis of their amino 
acid composition and structure (Boman 1995, Hancock 1997, Gennaro & Zanetti 2000, Brogden 
2005). One of the major difference between these peptides is the charge they may contain and 
hence the name anionic or cationic antimicrobial peptides, however cationic antimicrobial peptides 
are the most researched class (Faber et al. 2005).They have been isolated from single-celled micro-
organisms, insects and other invertebrates, plants, amphibians, birds, fish, and mammals, 
(including humans) (Martin &Ganz  1995, Wang & Wang 2004). 
They form the first line of host defence against pathogenic infections and are a key component of 
the ancient innate immune system (Wang & Wang 2004). To date, hundreds of such peptides have 
been identified (Hancock & Chapple 1999), indicating their importance in the innate immune 
system (Hancock & Diamond 2000). Collectively, they display direct microbicidal activities 
toward bacteria, fungi, and some parasites and viruses, although the importance of these activities 
in contributing to host defence may vary between sites within a particular organism and also 
between different types of organisms. Antimicrobial peptides can be expressed constitutively or 
induced by infectious and/or inflammatory stimuli, such as pro-inflammatory cytokines, bacteria, 
or bacterial molecules e.g., lipopolysaccharides (LPS) (Hancock 2001, Cunliffe & Mahida 2004). 
Some of these peptides are potent antimicrobials and their primary role is the killing of invading 
pathogenic organisms, however, it has been found that they may also function as modulators of the 
innate immune response in higher organisms (Gennaro & Zanetti 2000, Scott 2000, Yang et al. 
2004, Bowdish 2005). 
There is burgeoning literature on the use of AMPs as therapeutic antibiotics and other antimicrobial 
agents. However unfortunately, they are expensive to produce and are often sensitive to protease 
digestion (Beckloff et al. 2007). These features may however be corrected with the development 
of synthetic AMPs. 
18 
 
2.2.1 Categories and structural features of Cationic antimicrobial peptides  
Classification of peptides can be into several groups on the basis of their origin, activity spectrum 
or structure (Andreu & Rivas 1998, Dathe & Wieprecht 1999). Cationic antimicrobial peptides are 
generally categorized into four structural classes, α-helical, β-sheet, loop, or extended structures 
(Boman 1995, Hancock 1997, Jenssen et al. 2006); but there are many peptides that do not fit into 
this simplified classification scheme.  
The most common classes are β-sheet peptides stabilized by 2-4 disulfide bridges (and occasionally 
containing a short α-helical stretch), and unstructured peptides that fold into amphipathic α-helices 
upon contact with membranes. Less common are extended peptides with a predominance of one or 
two amino acids (e.g. proline, tryptophan or histidine) and loop peptides formed by a single 
disulfide bond. Other cationic antimicrobial peptides are formed by proteolytic digestion of larger 
cationic proteins such as lactoferrin (Hancock & Diamond 2000).  
Currently, more than 1,000 antimicrobial peptides have been reported from numerous different 
natural biological sources (Wang et al. 2009). Structure and sequence information on these peptides 
can be retrieved from the antimicrobial peptide database (http://aps.unmc.edu/AP/main.php and 




Figure 2.3: Protein models representing the structural differences of the four classes of 
antimicrobial peptides. Antimicrobial peptides can be grouped into four major classes based on 
their secondary structures, including the (A) α-helical peptides, (B) peptides composed of a series 
of β-sheets, (C) peptides that adopt unconventional structures, such as extended helices, and (D) 
peptides that assemble into loops. All structures were obtained freely from the RCSB Protein Data 
Bank (PDB) (http://www.pdb.org/) and have been referenced according to their Digital Object 
Identifier as stated in Berman et al. (2012) (Adopted with approval from Peters et al. 2010). 
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2.2.2 Historic background of antimicrobial biology 
A broad list of AMPs has been described in our environment. These peptides were first established 
as important in defence of lower phyla such as plants and are now appreciated as being important 
to the mammalian immune response for both their antimicrobial effects and diverse host effects 
(Izadpanah & Gallo 2005). 
Antimicrobial peptides produced by bacteria were among the first to be isolated and characterized 
(Mattick & Hirsch 1947). Their main role was highlighted as to contribute to the survival of 
individual bacterial cells via killing other bacteria that might compete for nutrients in the same 
environment. While they do not protect against infection in the classical sense, bacterial 
antimicrobial peptides, also called bacteriocins (Klaenhammer 1988, Riley 1998) are generally 
extremely potent compared with most of their eukaryotic counterparts. Bacteriocins have either 
narrow or broad spectrum activities, capable of targeting bacteria within the same species or from 
different genera. 
Further investigations in the early 1980s on insects, namely the Cecropia moth, identified a 37 
amino acid cationic peptide from the hemolymph called defensins (Steiner et al. 1981) . The 
synthetic versions of the Cecropion peptide showed potency against multiple gram-negative 
bacteria, including Escherichia coli and Pseudomonas aeruginosa (Jenssen et al. 2006). 
Investigations on mammals reported peptides in the granules of human and rabbit granulocytes 
(Ganz et al. 1985). The structural studies elucidated these defensins to be cationic, cysteine rich 
and ranging in size from 29 to 34 amino acids with a characteristic conserved amino acid pattern 
that included 6 cysteine residues involved in intramolecular disulfide bond formation. These AMPs 
were found to be bactericidal against both gram-negative and gram-positive bacteria and 
inactivated Cryptococcus neoformans and herpes simplex virus, type 1 (Ganz et al. 1985). 
Zasloff (1987) discovered magainins in the African clawed frog (Xenopus laevis) after noticing 
that surgical skin wounds healed without evidence of infection or visible inflammation in a non-
sterile environment and hypothesised that some form of antimicrobial agent was being expressed 
on the skin. These AMPs were subsequently processed and range in size from 23 to 27 amino acids 
with an unrelated primary sequence and a common feature of formation of an amphipathic, α-
21 
 
helical structure in hydrophobic environments. Their activity is due to cell lysis via disruption of 
cytoplasmic processes (Boman 1995). Since then AMPs have also been identified and 
characterized in many epithelial structures and appreciation of these molecules in human health 
and disease has led to extensive research (Izadpanah & Gallo 2005). 
2.2.3 Mechanisms of Cationic AMP action 
The expanding research to find an antimicrobial agent that would not be challenged by bacterial 
resistance as seen with conventional antibiotics (Davis 1996), has led to further research. One of 
the interests from this research boost has been the interest in antimicrobial peptides. The 
remarkable antibacterial selectivity of many peptides and their unique mode of action have made 
them promising candidates for the development of a new class of antibiotics (Hancock & Lehrer 
1998, Hancock 1999). Currently, considerable effort has been put toward elucidating the mode of 
action of these molecules with the aim of optimizing peptide antimicrobial activity (Bechinger 
1997, Matsuzaki 1998, Dathe 2000) 
Cationic antimicrobial peptides are the most researched class (Faber et al. 2005) with their 
antibacterial activity defined in detail (Dathe & Wieprecht 1999, Hancock & Patrzykat 2002 , 
Hancock & Rozek 2002). The properties of these peptides include a relatively short chain (12 to 
100 amino acids), a net positive charge (enhances interaction with anionic lipids and other bacterial 
targets), hydrophobicity (required for membrane insertion and often driven by this process), and 
flexibility (permitting the peptide to transition from its solution conformation to its membrane-
interacting conformation) (Jenssen et al. 2006). These characteristics can vary in each AMP in 
terms of amino acid sequence etc. However these basic characteristics are essential for the function 
of the peptides as antimicrobial agents, especially with their interaction with bacterial membranes 
(Jenssen et al. 2006). 
The original thought on the mode of action of antibacterial peptides was only by making the cell 
membrane permeable (Figure 2.4). However there is an increasing body of evidence that indicates 
that some antimicrobial peptides exert their effects through alternative modes of action (Jenssen et 
al. 2006).They may act upon multiple bacterial cell targets and intracellular processes by inhibition 




Irrespective of the different peptides’ precise modes of action, the activities of antibacterial 
peptides are almost always dependent upon interaction with the bacterial cell membrane (Hancock 
& Rozek 2002). The process starts by initial attraction between the peptide and the target cell, 
which is thought to occur through electrostatic bonding between the cationic peptide and negatively 
charged components present on the outer bacterial envelope, such as phosphate groups within the 
lipopolysaccharides of gram-negative bacteria or lipoteichoic acids present on the surfaces of gram-
positive bacteria (Jenssen et al. 2006). 
In gram-negative bacteria, peptides are inserted into the outer membrane structure in a process 
driven by hydrophobic interactions and possibly involving prefolding of the peptides into a 
membrane-associated structure; this leads to a disturbance of the outer membrane structure and 
makes this membrane permeable to other peptide molecules in a process termed self-promoted 
uptake. The net result is that the peptides arrive at the cytoplasmic membrane, where they enter the 
interfacial region of the membrane (the interface between the hydrophilic and hydrophobic portions 
of the membrane) in a process driven by electrostatic and hydrophobic interactions. The selectivity 
of antimicrobial peptides for bacterial cells over eukaryotic cells is by the presence of higher 
proportion of negatively charged lipids on the surface monolayer of the bacterial cytoplasmic 
membrane. However in eukaryotic cells, uncharged lipids predominate at the host cell surface 
(Jenssen et al. 2006). 
At the membrane surface the events that occur is considerably debated. Hence the proposal of 
several prominent models; barrel-stave, carpet, detergent, toroidal pore, and aggregate models are 
used to explain these events at present. Each of these models indicates a different type of 
intermediate that can lead to one of three types of events: formation of a transient channel, 
micellarisation or dissolution of the membrane, or translocation across the membrane. As a 
consequence of these processes, the peptide can permeabilize the membrane and/or translocate 
across the membrane and into the cytoplasm without causing major membrane disruption. 
Therefore, the modes of action of antibacterial peptides can be broadly categorized as either 
membrane acting or non-membrane acting.  
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2.2.4 Membrane-permeabilizing peptides 
Several different models have been proposed to explain membrane permeabilization. However the 
key characteristic for this process is the amphipathic nature of antimicrobial peptides. The 
hydrophobic regions are necessary to interact directly with the lipid components of the membrane, 
while hydrophilic regions either interact with the phospholipid head groups or face the lumen of 
the pore. In all models peptides first interact preferentially with the negatively charged lipid head 
groups at the membrane surface, adopting an orientation parallel to the membrane at the membrane 
interface.  
These models may have validity under different circumstances, and examination of a broad range 
of peptides with different sizes and structures has indicated that they leave quite different signatures 
of membrane interaction (Zhang et al. 2000). 
2.2.5 Aggregate model 
The aggregate model, which has some similarity to the toroidal pore model, can explain membrane 
permeabilization. Informal channels with a variety of sizes and lifetimes form (Wu et al.1999), and 
translocation across the bilayer occurs (Powers et al. 2005). In this model peptides reorient to span 
the membrane as an aggregate with micelle-like complexes of peptides and lipids as suggested by 
Matsuzaki et al. (1996, 1998b) and by the toroidal pore model. However in this model the peptides 
adopt no particular orientation. The model predicts that the lack of a formal channel structure will 
lead to channels that vary dramatically in character, that the peptide has the capacity to translocate 
across the bilayer as the aggregates collapse, and that the membrane will undergo negative 
curvature strain (Jenssen et al. 2006). 
2.2.6 Toroidal pore model 
In this model, aggregates of peptides insert themselves in an orientation perpendicular to the 
membrane to form a pore (Jenssen et al. 2006). The membrane curves inward to form a hole with 
the head groups facing towards the centre of the pore and the peptides line this hole. One prediction 
of this model is that the membrane will exhibit positive curvature strain due to the membrane 
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bending around to form the toroidal hole with the peptides within but the formation of a formal 
toroidal channel has yet to be shown (Jenssen et al. 2006).  
2.2.7 Barrel-stave model 
In this model (Ehrenstein & Lecar 1977) peptides re-orient to become the “staves” in a “barrel”-
shaped cluster which orients perpendicular to the plane of the membrane. The hydrophobic regions 
of each peptide in the cluster are associated with the lipid core, while the hydrophilic regions are 
facing the lumen of the newly formed transmembrane pore. This model predicts that there will be 
a consistent channel size (or substrates) and this is not true for most peptides (Jenssen et al. 2006). 
2.2.8 Carpet model  
In contrast to the barrel-stave and toroidal pore models, the carpet model proposes that aggregates 
of peptide align parallel to the lipid bilayer, coating local areas in a carpet-like fashion (Pouny et 
al. 1992). At sufficiently high concentration, this is thought to have detergent-like activity (causing 
patches of the membrane to break up into micelles). The local disturbances in membrane stability 
lead to the formation of holes in the membrane. Many cationic antimicrobial peptides will do this 
at high enough concentrations due to their amphipathic character; however, there is very limited 
evidence demonstrating that most peptides cause membrane dissolution at the minimal effective 
concentrations in vivo. In an in vitro study Zhang et al. (2001) examined nine representative 
peptides and demonstrated that most of them were able to cause membrane flip-flop at far lower 
concentrations than those at which they could cause calcein release, based on mechanistic studies. 
This mechanism has been proposed for ovispirin, antibacterial peptide based on the sheep 
cathelicidin Smap29 (Yamaguchi et al. 2001).  
2.2.9 Detergent Model 
The activities of certain peptides can be described in a general model which is based on their 
detergent-like properties (Bechinger 1999, 2005, Hallock et al. 2003). The model is based on the 
insertion of these amphiphilic peptides into the lipid bilayer with the nature of the molecules 
contributing to the variety of actions observed and the lipid polymorphism (Lohner 1991). The 
interaction of detergents with lipid membranes is complex. However the mechanism by which 
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cytolytic peptides finally damage the membrane will be determined by the peptide and lipid 
structure (Lohner & Blondelle 2005). Some of the theories are that depending on the peptide and 
membrane composition, the peptides form small and transient openings which is sufficient for the 
diffusion of smaller molecules, in and out of the cell. 
In order to get a complete description of the peptide–membrane interactions a variety of parameters 
and conditions need to be considered. These include the peptide-to-lipid ratio, the detailed 
membrane composition, temperature, hydration and buffer composition. Notably, the above 
mentioned carpet model can be included in the detergent-like properties of amphipathic peptides 
(Bechinger 2005).  
2.2.10 Non- Membrane permeabilizing peptides 
It is well established that several antimicrobial peptides cause bacterial death by membrane 
permeabilization, however at the minimal effective concentration this is not possible for most 
peptides. Despite this inability peptides have managed to cause cell death by translocating across 
the membrane and accumulating intracellularly, where they target a variety of essential cellular 
processes. Novel modes of action demonstrated include inhibition of nucleic acid synthesis, protein 
synthesis, enzymatic activity, and cell wall synthesis (Brogden 2005). 
The mode of action of individual peptides may differ depending on bacterial target cell, the 
concentration at which they are assayed, and the physical properties of the interacting membrane. 
Also its very likely that AMPs may use more than one mechanism of action, such as destabilization 
of the cell-membrane combined with inhibition of one or more intracellular targets, in the presence 




Figure 2.4: Events occurring at the bacterial cytoplasmic membrane following initial antimicrobial 
peptide (AMP) adsorption. (Adopted with approval from Nguyen et al. 2011) 
2.2.11 Advantages of peptides over other drug candidates 
AMPs have several advantages that may make them better candidates over other drugs (Vlieghe et 
al. 2010). Some of these advantages include: 
 The potential to penetrate further into any tissues that they are exposed to because of their 
small size (Ladner 2004), 
 Therapeutic peptides (even synthetic ones) are generally less immunogenic than 
recombinant proteins and antibodies (McGregor 2008), 
 Lower manufacturing costs (synthetic versus recombinant production), 
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 Higher activity per unit mass (15–60-fold, assuming 75 kDa for one combining site of an 
antibody and 10-50 amino acids for a therapeutic peptide), 
 Lower royalty pay-outs than antibodies because of a simpler intellectual property outline 
during discovery and manufacturing, Good stability (lengthy storage at room temperature 
acceptable), (Vlieghe et al. 2010)  
 Good potential for interaction with the immune system (assuming the peptide contains no 
known immune-system signalling sequence), 
 Offer greater efficacy, selectivity and specificity (limited non-specific binding to molecular 
structures other than the desired target) (Hummel 2006) than small organic molecules,  
 As the degradation products of peptides are amino acids, it minimizes the risks of systemic 
toxicity (minimization of drug–drug interactions) (Loffet 2002),  
 Due to their short half-life, few peptides accumulate in tissues (reduction of risks of 
complications caused by their metabolites). (Vlieghe et al. 2010) 
 Most therapeutic peptides, which are derived from natural peptides, are receptor agonists 
(Hruby 2002) hence small quantities of these peptide agonists are necessary to activate the 
targeted receptors (Lien & Lowman 2003).  
2.3 Peptidomimetics 
Peptide drug candidates have drawbacks like low stability in plasma, sensitivity to proteases and 
clearance from the circulation in a few minutes (Vlieghe et al. 2010). Therefore peptide research 
started to focus on peptidomimetics in order to overcome the limitations of peptides. 
Peptidomimetics are compounds whose essential elements (pharmacophore) mimic a natural 
peptide or protein in 3D space and which retain the ability to interact with the biological target and 
produce the same biological effect (Vagner et al. 2008). These mimetics have been synthesized 
using a variety of techniques and chemical optimization strategies. These strategies have been 
researched aiming at improving the limitations of these potential therapeutics. The synthetic 
peptide that this research will focus on is the cationic antimicrobial peptides BM2. 
2.3.1 Discovery of BM2 
BM2 was discovered based on the hypothesis that the incorporation of a cationic peptide-like motif 
into an antifungal would enhance its potency by concentrating the compound at fungal cell surfaces 
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(Monk et al. 2005). Screening of a compact 324-pool D-octapeptide library, which comprised 1.8 
million combinatorial pentapeptides linked to a C-terminal amidated triarginine motif, identified a 
potent, broad-spectrum, surface-active fungicidal Pma1p inhibitor. The combinatorial peptide 
library of the form D-NH2-A-B-X3-X2-X1-RRR-CONH2 (in which A and B are known) was 
prepared by using manual solid-phase 9-fluorenylmethoxy carbonyl chemistry by adapting a 
divide, synthesize, and mix strategy to a resin displaying the D-triarginine motif (Ostresh et al. 
1996, Niimi et al. 2004).  
Peptides contained D-amino acids (with cysteine and glycine excluded) to provide maximum 
biological stability during extended incubation with fungal cells. The C-terminal amidated 
triarginine motif was designed to mimic the patches of positive charge found in many cationic 
antimicrobial peptides. Arginine was chosen to maintain the positive charges over a wide, 
physiologically relevant pH range. The triarginine motif was expected to selectively target 
microbial cell surfaces and also to confer membrane impermeability because recent studies suggest 
that the passage of D-peptides across plasma membranes requires at least six consecutive arginine 
residues in the peptide (Mitchell et al. 2000).  
D-Octapeptide combinatorial library deconvolution screening identified the most active peptide 
library pools (Monk et al. 2005). The most suitable pool identified in stage 1 was then deconvoluted 
by cycles of re-synthesis and bioassay that sequentially determined the optimal amino acids for 
positions X3, X2 and X1. Further screening of combinatorial library pools and sub-pools were 
continued as only 3% of the pools gave > 90% growth inhibition. The pools with an N-terminal 
alanine (position A) and pools with tryptophan at position B were growth inhibitory at the greatest 
frequencies. The growth inhibition profiles showed that the primary sequences of the A and B 
amino acids in each D-octapeptide were important. 
A secondary screen was designed to identify pools that targeted Pma1p without affecting its 
cytoplasmic ATP binding site. Three pools (pools AW, AM, and RF), which best represented the 
most active growth-inhibitory and ATPase-inhibitory pools, were selected for deconvolution. 
Deconvolution of the RF (D-NH2-RFX3X2X1RRR-CONH2) pool selected the antifungal Pma1p 
inhibitor D-NH2-RFWWFRRR-CONH2 (BM0). Tests on the activity of BM0 highlighted its 
activity against S. cerevisiae but lack of potency against C. albicans.  
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The activity of D-NH2-RRRFWWFR-CONH2 indicated that N-terminal extension of BM0 with 
one or more arginine residues might improve the potency of the peptide against the fungal 
pathogens. This possibility was tested with D-NH2-RRFWWFRRR-CONH2 (BM1) and D-NH2-
RRRFWWFRRRCONH2 (BM2) (Niimi et al. 2005).  
2.3.2 Properties of BM2  
The optimization of BM0 led to the production of BM2. The ~1,600-Da lead D-decapeptide BM2 
has an aromatic core consisting of phenol-alanine and tryptophan (FWWF) bounded by a pair of 
triarginine motifs. It has two-fold greater fungicidal activity against S. cerevisiae, Candida species, 
and Cryptococcus neoformans. BM2 binds strongly to the surfaces of fungal cells, inhibits the 
physiological activity of Pma1p, and appeared to target Pma1p (Monk et al. 2005). The growth 
inhibitory concentrations of BM2 did not cause fungal cell permeabilization, significant 
haemolysis of red blood cells, or the death of cultured HEp2 epithelial cells (Monk et al. 2005). 
Research by Yoganathan (University of Otago DClinDent thesis 2012) on BM2 found microbicidal 
activity at concentrations several hundred fold lower than Sodium Hypochloride against planktonic 
cultures and biofilms of endodontic pathogens, including the significant endodontic pathogen 
Enterococcus faecalis. 
2.4 Detergents  
The term “detergent” is derived from the Latin word detergere, which means to wipe off (Effendy 
& Maibach 2006). Detergents are a group of synthetic organic chemicals commonly available as 
powders or concentrated solutions. They are also known as dispersing agents, wetting agents and 
surface-active agents or surfactants (Witton 1950). The term detergent has existed at least since 
1676 and until the 19th century the only man-made detergent had been natural soap. However the 
behaviour of soap in hard water which due to the presence of multivalent ions, inhibit soap’s 
foaming ability. Incentives to develop synthetic surface active agents in Europe after World War I 
saw the development of sodium lauryl sulphate an anionic surfactant in Germany (Löttermoser & 
Stoll 1933). These compounds are amphipathic, hence have 2 active parts- a hydrophobic, fat 
soluble portion and a hydrophilic, water soluble portion (Witton 1950). Amphipathic molecules 
exhibit unique properties in water; their polar group forms hydrogen bonds with water molecules 
while the hydrocarbon chains aggregate due to hydrophobic interactions. In aqueous solutions, they 
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form organized spherical structures called micelles (Fig 1.5), each of which contains several 
detergent molecules. Because of their amphipathic nature, detergents are able to solubilise 
hydrophobic compounds in water (Bhairi 2001), by reducing the interfacial tension between two 
immiscible phases. 
 
Figure 2.5: Illustration of a micelle. Actual micelle structures are more complex and dynamic, and 
can change due to detergent concentration and solution composition. (Adopted with approval from 
http://commons.wikimedia.org/wiki/File:Micelle_scheme-en.svg last accessed on 18.7.2016). 
In recent years detergent use has increased due to its many uses(Vincenzini et al. 1985) such as in 
laundry detergents, soapless soap, fuel additives and biological reagents. In biological sciences 
detergents are employed for the isolation and purification of integral membrane proteins found in 
biological cells. Advancements in the purity and sophistication of detergents have facilitated 
structural and biophysical characterization of important membrane proteins such as ion channels 
(Doyle et al. 1998), transporters, signalling receptors, and photosystem II (Umena et al. 2011). 
2.4.1 Classification of Detergents 
Detergents are based on the nature of the hydrophilic head group and can be broadly classified as 
ionic, non-ionic, and zwitterionic detergents. 
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Ionic detergents contain a head group with a net charge. They can be either negatively (anionic) or 
positively charged (cationic), contain either a hydrocarbon (alkyl) straight chain as in sodium 
dodecyl sulfate (SDS) and cetyltrimethylammonium bromide (CTAB), or a more complicated rigid 
steroidal structure as in sodium deoxycholate (bile acid salts).  
Most anionic detergents are alkylbenezenesulpfonates or salts of sulfonic acid, with the 
alkylbenzene portion being lipophilic and the sulfonate hydrophilic. The Two major varieties are 
those with branched alkyl groups and those with linear alkyl groups. These group of detergents are 
emulsifying, solubilising, wetting and cleaning agents but have relatively little antibacterial action 
(Witton 1950). 
Cationic detergents are similar to the anionic ones, with a hydrophobic component, but, instead of 
the anionic sulfonate group, the cationic surfactants have quaternary ammonium at the polar end. 
The ammonium centre is positively charged (Smulders et al. 2002) and they are alkaline in nature. 
They have a powerful antibacterial action and fungicidal properties, but not as much detergent 
action as the anionic compounds. These can be used as surfactants when solubilised in water; 
however their use is generally limited to antimicrobial preservatives because of their bactericidal 
activity (Attwood & Florence 1983, Zografi et al. 1990). They are most effective against gram-
positive cocci. Increasing concentrations kills intestinal gram negative rods however; gram 
negative bacilli are much more resistant. While higher concentrations or longer exposure time does 
not cause complete destruction of bacterial spores (Witton 1950).  
Similar charged detergent molecules repel each other in a micelle, hence the size of the micelle is 
determined by the combined effect of hydrophobic attraction of the side chains and the repulsive 
forces of the ionic groups. Micellar size increases with the increase in alkyl chain length and by 
neutralizing the charge on the head group with increasing concentrations of a counter ion (Bhairi 
2001). 
Non-ionic detergents contain uncharged, hydrophilic head groups that consist of either 
polyoxyethylene or a glycoside. They are better suited for breaking lipid-lipid and lipid-protein 
interactions than protein-protein interactions. These detergents are considered non-denaturant and 
are widely used in the isolation of membrane proteins in their biologically active form (Bhairi 
2001), and are also used as emulsifiers and solubilising and wetting agents. Their major 
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applications are in the food, cosmetic, paint, pesticide and textile industries (Reynolds 1999). The 
major advantage of non-ionic detergents is, they are compatible with all other types of surfactants 
and their properties are minimally affected by pH. Moreover they have been described as being 
less irritant than anionic or cationic surfactants (Effendy & Maibach 2006).  
Zwitterionic detergents offer the combined properties of ionic and non-ionic detergents. They are 
neutral in charge, lack conductivity and electrophoretic mobility, and don’t bind to ion-exchange 
resins. However, like ionic detergents, they are efficient at breaking protein-protein interactions 
(Bhairi 2001) and reducing aggregation. These properties have been used for chromatography, 
mass spectrometry, and electrophoresis methods, and solubilisation of organelles and inclusion 
bodies (Caligur 2008).These surfactants have received much less attention than the other groups. 
Many of them have excellent wetting ability however most of them are not antibacterial (Witton 
1950). 
 
Figure 2.6: Detergent classification. (Adopted with approval from Seddon et al. 2004) 
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2.4.2 General Properties of Detergents 
The performance and properties of a detergent is dependent on a number of factors. These include 
detergent concentration, organic additives presence, ionic strength purity, length of the alkyl chain, 
temperature and pH. These properties include (Caligur 2008): 
 Cleaning and wetting of surfaces 
 Use as a preservative 
 Use as an antimicrobial 
 Disruption of the bipolar lipid membrane of cells in order to release and solubilize 
membrane-bound proteins.  
 Solubilisation of recombinant proteins,  
 Stabilisation, crystallisation, or denaturation of proteins.  
 Alignment at aqueous/non-aqueous interfaces, resulting in reduced surface tension, 
increased miscibility, and stabilization of emulsions.  
 Extraction of DNA and RNA 
 Solubilisation of specimens for diagnostic applications 
 Cell lysis 
 Liposome preparation 
 Prevention of reagent and analyte precipitation from solution 
 Prevention of non-specific binding in immunoassays 
 Utilisation in the food and cosmetic industry 
2.4.3 Critical Micelle Concentration (CMC) 
The CMC is defined as the lowest concentration above which monomers cluster to form micelles, 
or the maximum attainable chemical potential (concentration) of the monomer. Micellization 
occurs over a narrow concentration range rather than at a particular concentration. CMC decreases 
with the length of the alkyl chain and increases with the introduction of double bonds and other 
branched points and additives, such as urea. In ionic detergents, the CMC is reduced by increasing 
the concentration of counter ions (Bhairi 2001).  
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A lower CMC indicates a more stable micelle depicting that molecules are incorporated into or 
removed from the micelle more slowly. The micelle structure is affected by the structure of the 
hydrophobic region of the detergent. An increase in the length of the hydrophobic hydrocarbon 
chain of ionic detergents causes an increased micelle size therefore a lower CMC, because fewer 
molecules are needed to construct a micelle (Caligur 2008). 
The CMC value can be a useful guide to hydrophobic binding strength of detergents. Detergents 
with higher CMC values have weaker binding hence are easier to remove. However detergents 
with low CMC require less detergent to form micelles and solubilize proteins or lipids (Caligur 
2008). 
2.4.4 Krafft Point 
At very low temperatures detergents remain mainly in an insoluble crystalline state with small 
amounts of dissolved monomers. An increase in temperature will cause more of the detergent 
monomers to solubilise until the concentration of the detergent reaches the CMC Kraft Point is the 
minimum temperature at which micelles form or the temperature at which all the three phases - 
crystalline, micellar and monomeric exist in equilibrium. Krafft point has been named after the 
German chemist Friedrich Krafft and for most detergents is identical to the Critical Micelle 
temperature (CMT) (Bhairi 2001). 
2.4.5 Cloud Point 
At a particular temperature above or near the CMT, a detergent solution separates into two phases.  
At this temperature non-ionic detergents become cloudy and undergo phase separation to yield a 
detergent-rich layer and an aqueous layer which is called the cloud point (Bhairi 2001). 
The two-phase solution can be separated, and the extracted protein will be found in the detergent-
rich phase. This property has been applied in the phase separation and purification of membrane 
proteins. Factors that can affect the cloud point are changes in detergent concentration, temperature, 
and the addition of salt or polymers such as dextran and polyethylene glycol (Arnold & Linke 2007, 
Caligur 2008).  
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2.4.6 Aggregation Number 
This is the average number of monomers contained in a single micelle. Aggregation number and 
CMC values are influenced by factors such as temperature, pH, ionic strength, and detergent 
homogeneity and purity. Aggregation number values can also be changed by concentration, as the 
number of detergent molecules per micelle may increase if the concentration is above the CMC 
(Bhairi 2001, Caligur 2008). 
2.4.7 Hydrophile-Lipophile Balance (HLB) 
The molecular structure and balance of detergents depicts how hydrophobic or hydrophilic it is. 
Literature describes this as Hydrophile-Lipophile Balance (HLB) which is helpful in characterising 
detergents (Krugliakov 2000, Hait & Moulik 2001, Bhairi 2001). 
The larger the HLB, the more hydrophilic is the detergent hence, have high water solubility and 
are good stabilisers of oil and water emulsions. HLB number ranges from 0 to 40 and a HLB 
number <10 indicates that a detergent has low solubility in water while an HLB number between 
10 and 20 indicates that the detergent is readily soluble in water (Krugliakov 2000). There appears 
to be some correlation between the HLB value of a detergent and its ability to solubilise membrane 
proteins (Hait & Moulik 2001, Bhairi 2001).  
2.4.8 Mechanism of Membrane Proteins solubilisation by Detergents 
The mechanism by which detergents solubilise membrane proteins is by mimicking the lipid-
bilayer environment. The bilayers of the biological membranes resemble micelles formed by 
detergents hence; proteins incorporate into these micelles via hydrophobic interactions. Once this 
occurs, the hydrophobic regions of membrane proteins get surrounded by detergent molecules and 
the hydrophilic portions are exposed to the aqueous medium therefore, keeping the membrane 
proteins in solution. This dissolution of membrane proteins can occur in different stages depending 
on the concentration of the solution (Fig 2.7). When the concentration of the solution is low, 
detergents bind to the membrane proteins by partitioning into the lipid bilayer. However at higher 
concentrations the membranes disintegrate to form mixed micelles with the detergent molecules. 
In the solution there is presence of detergent-protein mixed micelles, where the hydrophobic 
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regions of the membrane proteins are surrounded by the hydrophobic chains of micelles and or 
micelles of lipids and detergents. 
Once the membranes are solubilised micelles containing protein-detergent molecules can be 











Figure 2.7: Stages in the dissolution of a biological membrane with detergents. (Adopted with 
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2.4.9 Polysorbate 20 
Polysorbate 20 is a polysorbate-type non-ionic surfactant with a chemical formula of C58H114O26 
and molecular mass of 1227.54 g/mol (Fig 2.8). The common commercial brand names include 
Polysorbate 20, PEG (20) sorbitan monolaurate, Scattics, Alkest TW 20 and Tween 20. It is a clear, 
yellow to yellow-green viscous liquid which is formed by the ethoxylation of sorbitan before 
adding lauric acid. As the name implies the ethoxylation process leaves the molecule with 20 repeat 
units of polyethylene glycol. In practice these are distributed across 4 different chains leading to a 
commercial product containing a range of chemical species (Ayorinde et al. 2000). Tween 20 is 
quite stable and relatively nontoxic hence, its popularity for use as a detergent and emulsifier in a 
number of domestic, scientific, food industry and pharmacological applications. 
 
Figure 2.8: Polysorbate 20 chemical structure. 
2.4.10 Cetyltrimethylammonium bromide (CTAB) 
Cetyltrimethylammonium bromide (CTAB), also known as Cetrimonium bromide and 
hexadecyltrimethylammonium bromide, has the chemical formula (C16H33)N(CH3)3Br (Fig 2.9). It 
is a cationic surfactant/quaternary ammonium compound (QAC) and appears as white powder with 
a molecular mass of 364.45 g/mol. The hexadecyltrimethylammonium cation is an effective 
antiseptic agent against bacteria and fungi. Its uses are varied and include providing a buffer 
solution for the extraction of DNA, and the synthesis of gold nanoparticles and mesoporous silica 
39 
 
nanoparticles that are widely used in hair conditioning products, disinfectants for manual 
processing lines and surfaces in the food industry, and in human medicine (Mereghetti et al. 2000). 
At 30°C it forms micelles with an aggregation number between, 75-120 (depending on method of 
determination, usually average ~95) and degree of ionization α (fractional charge) 0.2-0.1 (from 
low to high concentration).  
 
Figure 2.9: Cetyltrimethylammonium bromide (CTAB) chemical structure. 
CTAB is also utilised in protein electrophoresis. Because of the broad distribution of negative 
charges in glycoproteins, these form broad, fuzzy bands in SDS-PAGE (Laemmli-electrophoresis) 
(Laemmli 1970). This can be avoided by using positively charged detergents like CTAB (Buxbaum 
2003, 2009) instead of the negatively charged SDS.  
The antimicrobial action of CTAB is due to the cell membrane rupture by both chemical reactions 
and electrostatic effects (Simões et al. 2006). Their positive charge, allows them to form 
electrostatic bonds with negatively charged sites on microbial cell walls (McDonnell & Russell, 
1999) which create stresses in the wall, leading to cell lysis and death. QACs are also known to 
cause cell death by protein denaturation, disruption of cell-wall permeability, and reduction of the 
uptake of essential nutrients (Cloete et al. 1997). Gilbert et al. (2002) suggested that the primary 
site of action of CTAB is the lipid component of the membrane with cell lysis being a secondary 
effect. 
2.4.11 Sodium dodecyl sulphate (SDS) 
Sodium dodecyl sulfate (SDS), is an organic compound with the formula CH3(CH2)11SO4Na (Fig 
2.10) and a molar mass of 288.372 g/mol. It is a white or cream-coloured solid, odourless anionic 
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surfactant derived from inexpensive coconut and palm oils used in many cleaning and hygiene 
products (Smulders et al. 2002). SDS is an organosulfate consisting of a 12-carbon tail attached to 
a sulfate group, giving the material the amphiphilic properties required of a detergent. Other names 
that this product is known by are, sodium monododecyl sulfate, sodium lauryl sulfate, sodium 
monolauryl sulfate, sodium dodecanesulfate, sodium coco-sulfate, dodecyl alcohol, hydrogen 
sulfate, sodium salt, n-dodecyl sulfate sodium and sulfuric acid monododecyl ester sodium salt.  
 
Figure 2.10: Sodium dodecyl sulphate (SDS) chemical structure. 
SDS is probably the most researched anionic surfactant compound, and has many applications. Its 
major laboratory applications includes aiding  in lysing cells during DNA extraction and 
unravelling proteins and in preparing proteins for electrophoresis in the sodium dodecyl sulfate-
polyacrylamide gel electrophoresis technique (Weber & Osborn 1969). 
The mechanism by which this compound works is by disrupting proteins non-covalent bonds, 
denaturing them, and causing the molecules to lose their original shape. This causes the formation 
of a new negative charge which is significantly greater than the original charge of that protein. The 
electrostatic repulsion that is created by binding of SDS causes proteins to unfold, into a rod-like 
shape thereby eliminating differences in shape as a factor for separation in the gel. 
The  critical micelle concentration (CMC) of SDS in pure water at 25°C is 8.2 mM (Mukerjee & 
Mysels 1971) and the aggregation number at this concentration is usually considered to be about 





Previous research done by research team at the University of Otago on a synthetic cationic peptide, 
BM2, found microbicidal activity against planktonic cultures and biofilms of endodontic 
pathogens, including the significant endodontic pathogen Enterococcus faecalis, at concentrations 
several hundred-fold lower than the endodontic irrigant, sodium Hypochlorite (Yoganathan 
University of Otago DClinDent thesis 2012) and the intra-radicular medicament, calcium 
Hydroxide (Othman University of Otago DClinDent thesis 2014). Similarly, work with other short 
chain peptides has shown promising results in limiting bacterial and Candida cell growth 
(Tasmania RL, University of Otago DClinDent thesis 2012) and invasion of dentine (Love RM, 
unpublished results).  
However elimination of a biofilm requires both bacteriocidal activity and disruption of the extra 
cellular matrix and biofilm structure. Previous work showed the bacteriocidal effect of BM2 
however, it is not effective at disrupting the biofilm structure. This research was conducted to 
investigate if a combination of BM2 and a detergent enhanced elimination of monospecies biofilms 
of microorganisms related to pulp & periapical disease.  
The objectives of this study were: 
To investigate if a detergent regime will enhance the antimicrobial ability of BM2 
 
i) To investigate if Sodium dodecyl sulphate will enhance the efficacy of BM2 against mono 
species bacterial and candida biofilms,  
  
ii) To investigate if Cetyltrimethyl ammonium bromide will enhance the efficacy of BM2 
against mono species bacterial and candida biofilms and 
 
iii) To investigate if Polysorbate 20 will enhance the efficacy of BM2 against mono species 





The addition of SDS and CTAB will enhance the antibacterial property of BM2 however; Tween 





Chapter 3 Materials and methods 
3.1 Source and storage of micro-organisms 
The micro-organisms used in this study (Table 3.1) were obtained from the Molecular Biosciences 
Laboratory culture collection at the University of Otago, New Zealand. American Type Culture 
Collection (ATCC) strains were selected to provide a panel of representative microorganisms 
relevant to endodontics, act as suitable controls and enable comparison with previous AMP 
research in the School of Dentistry. The strains obtained from frozen glycerol stocks were 
inoculated on agar plates that enabled the confirmation of phenotypes characteristic of each species.  
Frozen stocks kept at -70oC were thawed, vortexed and inoculated by streaking onto Columbian 
Sheep blood agar plates (Richard Laboratories Ltd, Auckland, New Zealand), Mutans selective 
media (Richard Laboratories Ltd, Auckland, New Zealand) or sabouround dextrose agar plates 
with antidom (Richard Laboratories Ltd, Auckland, New Zealand ) plates, as appropriate, in order 
to give single colonies. The agar plates inoculated with bacterial strains were incubated for 24 hr 
anaerobically in a modular atmosphere controlled system (Don Whitney Scientific Ltd, Stipley, 
West Yorkshire, UK). Candida albicans was incubated aerobically in a 30°C oven. Once 
phenotypes were confirmed by observing characteristic of the specific bacteria and yeast, further 
testing was carried out using PCR, 16S ribosomal RNA (rRNA) gene sequencing tests to confirm 
the species for the experiments. 
After confirmation of the strains, single colonies of bacterial strains with the expected phenotype 
were subcultured on brain heart yeast (BHY) agar plates while C. albicans was subcultured on 






Table 3.1: Panel of microorganisms 
Strain Gram-
stain 
Anaerobe type  Role in endodontics 
Streptococcus gordonii  (DL1) Positive Facultative Initiation of primary 
infection 
Streptococcus mutans  (NG8) Positive Facultative Initiation of primary 
infection 
Enterococcus faecalis  (JH2-2) Positive Facultative Refractory infection 
Candida albicans  (ATCC 10261) Positive Facultative Refractory infection 
 
3.2 Preparation of media 
3.3 Brain heart yeast agar plates 
Brain heart yeast (BHY) is an enriched non-selective medium that was chosen for growth of the 
bacteria used in the present study. It is a highly nutritious  general purpose growth media for 
culturing fastidious and non-fastidious microorganisms. 
 
Media for BHY agar plates were made by mixing 37g of brain heart infusion, 5g of yeast extract 
and 15g of agar in 1 l of distilled water. The mixture was autoclaved at 121°C for 20 min, cooled 
for 60 min, equilibrated at 55°C and 30 ml aliquots poured into Petri dishes under sterile conditions 
and left to set overnight. The plates were stored in a refrigerator at 6°C until required. 
3.4 YPD agar plates 
Yeast extract peptone dextrose (YPD) agar plates and broth are used for maintaining and 
propagating yeasts cells. It consists of yeast extract, peptone, glucose or dextrose in distilled water 
for broth and adding agar to it would make it a solid media. YPD media was used for the growth 
of C. albicans.  
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Media for YPD agar plates were made by mixing 20g of bacterial peptone, 10g yeast extract, 20g 
glucose and 15g agar with 1 l of distilled water. The mixture was autoclaved at 121°C for 20 min, 
cooled for 60 min, equilibrated at 55°C and 30 ml aliquots poured into Petri dishes under sterile 
conditions and left to set overnight. The plates were stored in a refrigerator at 6°C until required. 
3.5 Tryptic Soy broth 
Tryptic soy broth (TSB), is a general purpose medium, for the cultivation of a wide variety of 
microorganisms. This media is commonly referred to as Soybean-Casein Digest Medium, and 
abbreviated as TSB. The nitrogen sources in this broth, is from the enzymatic digest of casein and 
soybean meal. The carbon energy source that facilitates organism growth is dextrose and sodium 
chloride maintains osmotic balance while dipotassium phosphate acts as a buffering agent 
(Acumedia, Tryptic Soy broth PI 7164, Rev 06, Nov 2010.) 
Tryptic soy broth was made by adding 30g of TSB powder with a litre of sterile distilled water 
(DH2O) and distributed into laboratory glass bottles and glass universal tubes and autoclaved at 
121⁰C for 15 min in a high-pressure steam autoclave (Tomy Seiko Co. Ltd., Tokyo, Japan) prior 
to use.  
3.6 Complete Supplement Mixture (CSM) 
Complete Supplement Mixture (CSM) is a combination of amino acids, vitamins and other 
essential components to support vigorous growth of cells. 
Complete Supplement Mixture was made by adding 6.7g yeast nitrogen base without amino acid, 
0.77g CSM powder, 20g glucose, 1.95g MES (10mM), 4.77g HEPES (20mM), 1.67g TRIS powder 
to a liter of distilled water and distributed into laboratory glass bottles and glass universal tubes 
and autoclaved at 121⁰C for 15 min in a high-pressure steam autoclave (Tomy Seiko Co. Ltd., 
Tokyo, Japan) prior to use. 
Prior to use the pH of the medium was checked and adjusted to 6.8 then filter sterilized. 
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3.7 Preparation of inoculums 
Single colonies taken from stock plates were subcultured on BHY or YPD agar plates prior to 
liquid culture in TSB and CSM broth. Few colonies were transferred using a sterile loop into 3 ml 
sterile broth and incubated for 24 hr at 30⁰C or 37⁰C. Three ml of the resultant microbial suspension 
was adjusted to OD600nm = 0.5 i.e. approximately 5 x 10
8 colony forming units (CFU)/ml for the 
bacteria and 107 CFU/ml for C. albicans. The culture was diluted 1:100 by adding 200 μl to 19.8 
ml of the appropriate broth, which gave approximately 5 x 106 CFU/ml and 105 CFU/ml as the 
starting inoculum for bacteria and C. albicans, respectively.  
3.8 Preparation of test substance 
3.8.1 Preparation of detergents 
Sodium dodecyl sulphate (SDS) (Life technologies, Thermo Fisher Scientific, Waltham, USA), 
cetyltrimethylammonium bromide (CTAB) (Sigma, Thermo Fisher Scientific, Waltham, USA) and 
polyoxyethylene sorbitan monooleate (Tween 20) (Bio-rad, California, USA) were prepared in 
DH2O at various concentrations and serially diluted for experiments (Figure 3.1). These 
preparations were filter sterilized using a syringe filter (Millex-GP 0.22um 33mm. PVDF) 
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3.8.2 Preparation of BM2 
Antimicrobial peptide BM2 was sourced from GenScript (GenScript, New Jersey, USA). The 
peptide was delivered as a fluffy lyophilized material estimated at > 95% purity and was stored at 
-20°C. Prior to experiements the total peptide content was checked by spectrophotometric analysis. 
This was done by taking a 1.62 mg sample of the thawed peptide and dissolving it in 100 μl 
phosphate buffered saline (PBS). Two microlitres of the peptide solution was  pipetted into 198 μl 
PBS in a well of a 96 well microtitre plate.  Serial 2-fold dilutions were done to get BM2 samples 
in the range containing 1.62 – 0.0253 µg/ml. The BM2 samples were transferred into cuvettes and 
subjected to spectrophotometric analysis to determine their absorbance at 280 nm, with PBS as a 
blank. A molar extinction coefficient of 11,000 M.cm-1 was used to calculate the theoretical 
concentration of the BM2. 
Prior to experiments BM2 was solubilized in DH2O to get a 3000 µg/ml concentration solution, 
which was prepared to various concentrations prior to experiments. 
3.9 Determination of MIC values for planktonic cells 
Minimum inhibitory concentration (MIC) is the lowest concentration of a test substance that will 
inhibit the growth of microorganism after incubation. It is considered the best method for 
determining the susceptibility of organisms to an antimicrobial agent. Minimum inhibitory 
concentrations help confirm resistance of microorganisms to an antimicrobial agent and also to 
monitor the activity of new antimicrobial agents (Andrews 2001).  
The MIC of each microorganism for the tested compounds (detergent or BM2) was determined as 
the lowest concentration that inhibited growth completely i.e. gave turbidity equal to or less than 
the initial inoculum.  
3.9.1 MIC of detergents 
Serial two-fold dilutions of compounds to be tested were added as 100 μl samples in wells of a 96 
well microtitre plate. Microbial inoculums (100 μl) were then added to selected wells of the 
microtitre plate. A standard setup for the assay is shown below (Figure 3.2). 
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At time 0 hr a microplate reader (Synergy 2, BioTek, Vermont, USA) was used to record the initial 
cell density in each well at OD600nm. Microtitre plates containing bacteria were incubated under 
anaerobic conditions at 37°C for 24 hr in a modular atmosphere controlled system (Don Whitney 
Scientific Ltd, Stipley, West Yorkshire, UK). Microtitre plates containing C. albicans were 
incubated at 30°C for 24 hr under aerobic conditions with shaking. The negative control wells 
contained 100 μl of sterile broth plus 100 μl of sterile distilled water. A set of positive controls 
contained 100 μl inoculated broth plus 100 μl sterile distilled water where growth of organisms 
was expected. 
After 24 hr incubation period the OD600nm was measured using a Synergy 2 microplate reader 
(BioTek, Vermont, USA). The 0 hr and 24 hr OD readings were compared and Student’s t-tests 
were done for the OD results to find out if there were significant difference between the controls 
and the experiment. 
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 CTAB: 100μL of SDS + 100μL inoculated broth 
            TW 20: 100μL of SDS + 100μL inoculated broth 
            100 μL Inoculated broth + 100 μL of PBS 
Figure 3.2: Determination of MIC values for planktonic cells with detergents. 
 
3.9.2 MIC of BM2 
Serial two-fold dilutions of various concentrations of BM2 (20 μl) were added to wells of a 96 well 
microtitre plate. Microbial inoculums (180 μl) were then added to selected wells of the microtitre 
plate. A standard setup for the assay is shown below (Figure 3.3). 
At time 0 hr, a microplate reader (Synergy 2, BioTek, Vermont, USA) was used to record the initial 
cell density in each well as OD600 nm.  
Microtitre plates containing bacteria were incubated under anaerobic conditions at 37°C for 24 hr 
in a modular atmosphere controlled system (Don Whitney Scientific Ltd, Stipley, West Yorkshire, 
UK). Microtitre plates containing C. albicans were incubated at 30°C for 24 hr under aerobic 
conditions with shaking. Plates were removed from the incubator and the controls checked. 
Negative control wells contained 180 μl of sterile broth and 20 μl of sterile distilled water. Positive 
control wells contained 180 μl of microorganism suspension in liquid medium and 20 μl of sterile 
distilled water.  
The MIC for various BM2 preparations was read as the lowest concentration of antimicrobial agent 
that completely inhibited growth of the organism as represented by the last clear well that was free 
of sedimentation.  
The final cell density of each well was read at OD600nm after 24 hr incubation. The data collected 
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Figure 3.3: Determination of MIC values for planktonic cells with BM2. 
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 Control: 20μL of sterile broth + 180 ul of PBS  
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 Serial dilution of test substance + 180 μl inoculated broth 
  20ul of BM2: 20μL of BM2 + 180 μl inoculated broth 
  180 μL Inoculated broth + 20 μl of PBS 
 
3.10 MIC of detergent and BM2 combinations 
The compounds to be tested were added as 50 μl samples  in wells of a 96 well microtitre plate. 
Microbial inoculums (100 μl) were then added to selected wells of the microtitre plate. A standard 
setup for the assay is shown below (Figure 3.4). 
At time 0 hr, a microplate reader (Synergy 2, BioTek, Vermont, USA) was used to record the initial 
cell density in each well as OD600 nm.  
Microtitre plates containing bacteria were incubated under anaerobic conditions at 37°C for 24 hr 
in a modular atmosphere controlled system (Don Whitney Scientific Ltd, Stipley, West Yorkshire, 
UK). Microtitre plates containing C. albicans were incubated at 30°C for 24 hr under aerobic 
conditions with shaking. Plates were removed from the incubator and the controls checked. 
Negative control wells contained 100 μl of sterile broth and 100 μl of sterile distilled water. Positive 
control wells contained 100 μl of microorganism suspension in liquid medium and 100 μl of sterile 
distilled water.  
The MIC for various BM2 and detergent preparations was read as the lowest concentration of 
antimicrobial agent that completely inhibited growth of the organism as represented by the last 
clear well that was free of sedimentation.  
The final cell density of each well was read at OD600nm after 24 hr incubation. The data collected 






The concentration at which the antimicrobials worked were noted and these perimeters were 
utilized in the preceding experiments. 
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 Control: 100µ1 of sterile broth + 100 μL of sterile distilled water 
Serial dilution of test substance: 50 μL detergent + 50 μL BM2 + 100μL inoculated     broth 
  50 μL of BM2 + 50 μL of sterile distilled water + 100μL inoculated broth 
             50 μL of BM2 + 50 μL of sterile distilled water + 100μL inoculated broth 
  100 μL Inoculated broth + 100 μL of sterile distilled water 
Figure 3.4: Determination of MIC values for planktonic cells with detergent and BM2 combination. 
 
3.11  Statistical analysis 
The optical density of the microorganisms at 0 hr and 24 hr were statistically analysed using the 
paired Student’s t-test for comparison. P values of < 0.05 were considered significant. Three 
independent experiments were performed in triplicate to provide nine sets of data. The optical 
density values were presented as means ± standard deviation of the means (SD). The mean optical 
densities and SD were calculated using Microsoft Office Excel software package.  
3.12  Minimum bactericidal concentration (MBC) for planktonic cells 
The MBC is the lowest concentration of an antimicrobial agent that will kill a microorganism. The 
MIC provides important information in antimicrobial discovery. However the disadvantage is that 
it only measures the ability to block cell growth within a standard time frame. The MBC can be 
determined from the MIC broth microdilution tests by using the contents of the wells with no 





The range of test concentrations that displayed inhibition of microorganism growth was used to 
determine the MBC. A portion (20 μl) from each of the wells was plated onto BHY agar plates for 
bacterial species and YPD agar plates for Candida. Incubation for bacterial species was under 
anaerobic conditions at 37°C for 24 hr in a modular atmosphere controlled system (Don Whitney 
Scientific Ltd, Stipley, West Yorkshire, UK). C.albicans strain was incubated at 30oC for 24 hr 
under aerobic conditions. The MBC for the test species was determined as the lowest antimicrobial 
concentration from which no colonies were detected. 
3.13  Effect of test substances on biofilm 
3.13.1  Biofilm formation 
Mono-species biofilms were produced from cells that were initially inoculated in 3 ml of sterile 
broth and grown to a stationary phase overnight. One ml of suspension was then adjusted to 
OD600nm = 0.5 i.e. approximately 5 x 10
8 colony forming units (CFU)/ml for the bacteria and 107 
CFU/ml for C. albicans. The culture was diluted 1:100 by adding 200 μl to 19.8 ml of the 
appropriate broth, which gave approximately 5 x 106 CFU/ml and 105 CFU/ml as the starting 
inoculum for bacteria and C. albicans, respectively.  
An inoculum of 180 l of the broth was added to each well using a multi-channel pipette. The final 
organism concentration per well was estimated to be at 9 x 105 CFU. For the control, four wells of 
the microtitre plate was filled with 200 l of sterile broth.  
The microtitre plates were closed with sterile plastic lids and incubated at 37°C with 5% CO2 for 
72 hr in a modular atmosphere controlled system (Don Whitney Scientific Ltd, Stipley, West 
Yorkshire, UK). Planktonic bacteria was removed from the microtitre plates every 16 to 18 hr by 
using a multichannel pipette to remove 180 l of the growth medium and replacing it with 180 l 
sterile broth. After 72 hr incubation, a multichannel pipette tip was used to remove the sterile broth 
and planktonic bacteria. The wells were washed twice with PBS to remove unattached bacteria.  
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3.13.2 Exposure of biofilm to antimicrobials 
Biofilms grown in microtitre plates were exposed to serial dilutions of test substances, at 
concentrations that had been found from initial experiments. Washed wells, as above, with attached 
biofilms were exposed to 100 μl (detergent and BM2) of test material combinations for either 24, 
48 or 72 hr. The plate setup (Figure 3.4) was the same as the planktonic cell exposure to 
antimicrobials without addition of 100 μl of inoculated broth. However the antimicrobial 
concentrations were adjusted from the planktonic cells experiments.  
3.14  Biofilm assay 
The crystal violet assay was used to test the effect on the biofilm. 
3.14.1  Crystal violet assay 
Crystal violet dye was prepared by diluting 1 g of crystal violet powder in 1000 ml water. The 
solution was filtered aseptically using a sterile 22 mm syringe filter into a laboratory glass bottle. 
Prior to crystal violet assay, the contents of the 96-well microtitre plates were emptied and the 
wells were washed 3 times with PBS and left to dry for 15 min. 125 μl of 0.1% crystal violet 
solution was added to each well and allowed to stain for 15 min. Each plate was shaken over a 
discarded tray to remove the crystal violet solution. The wells were washed again with PBS 3 times 
until the non-bound crystal violet was discarded. The microtitre plate was laid inversely on a paper 
towel for 24 hr to dry after a brisk tapping to remove excess liquid.  
The bound crystal violet was solubilised by the addition of 200 μl of 95% ethanol to each well. The 
ethanol was pipette up and down thoroughly in order to dissolve the crystal violet using a 
multichannel pipette. The lids of the microtitre plates were replaced and ethanol was kept in the 
wells for 15 min at room temperature. The optical density of each well was read at OD600nm.  
For wells whose OD reading could not be detected. 20 μl of each well content was removed and 
diluted ten folds and another reading was carried out at OD600nm. 
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3.15 Statistical analysis 
The optical density values of the crystal violet solubilized biofilms were statistically analysed using 
the Students t-test. A 0.05 level of confidence was used and P values of < 0.05 were considered to 




Chapter 4 Results  
4.1 Spectrophotometric analysis of BM2 
The peptide BM2 (sequence: D-NH2-RRRFWWFRRR-CONH2) was synthesized by Peptide 2.0 
(Chantilly, Virginia, USA) at a purity estimated to be 95-99%. Based on a molar extinction 
coefficient at 280 nm of 11,000 M-1.cm-1 (http://web.expasy.org/cgi-bin/protparam/protparam), 
spectrophotometric analysis of the peptide powder dissolved in sterile phosphate buffer saline 
(PBS) showed that the peptide contributed approximately 40% of the weight of the powder. As 
BM2 contains 7 positive charges, it is likely that these are counterbalanced by negatively charged 
trifluoracetic acid molecules. The concentration of BM2 was therefore calculated using the molar 
extinction coefficient of BM2 at 280 nm which is dependent on the presence of two tryptophans 
and two phenylalanines in each molecule.  
 




























4.2 Minimum inhibitory concentration 
The antimicrobial peptide BM2 and the various detergents tested showed different bacteriostatic 
activities against the microorganism test panel. The MIC values for the antimicrobials tested are 
shown in Table 4.1. 
The results showed that BM2 was effective against all the test organisms with MIC values between 
4 and 64 μg/ml (Fig 4.2). The most susceptible strain was S. mutans (NG8) and the least susceptible 
was E. faecalis (JH2-2). 
From the detergents tested polyoxyethylene sorbitan monooleate (Tween 20) (Bio-rad) did not 
inhibit growth of the organisms tested (Table 4.1).  
Cetyltrimethylammonium bromide (CTAB) (Sigma) was the most effective (at lowest 
concentration) in inhibiting the tested organisms (Table 4.1, Fig 4.3). The MIC was 38.8 x 10-5 
μg/ml for S. mutans (NG8), C. albicans (ATCC 10261), S. gordonii (DL1) and E. faecalis (JH2-
2).  
Sodium dodecyl sulphate (SDS) (Life technologies, GibcoBRL) inhibited growth of the test 
organisms with MIC values between 200 and 400μg/ml (Table 4.1, Fig 4.4). The most susceptible 
strains were S. mutans (NG8) and E. faecalis (JH2-2). The least susceptible organism was C. 









Table 4.1: Table of MIC and MBC of planktonic cells and tested substances. 
Organisms tested Test 
substance 
MIC (μg/ml ) MBC (μg/ml ) P value 
S. mutans (NG8) BM2 4 8 2.52 x 10-13 
 SDS 200 400 0.01 
 CTAB 38.8 x10-5   
 TW 20 > 40  > 40    
E. faecalis (JH2-2) BM2 64 > 128   2.73 x 10-13 
 SDS 200 400 0.03 
 CTAB 38.8 x10-5 > 38.8 x10-5 0.02 
 TW 20 > 40   > 40    
S. gordonii (DL1) BM2 16 16  
 SDS 400 400 0.02 
 CTAB 38.8 x10-5 > 620 x10-5 6.23 x 10-6 
 TW 20 > 40  > 40    
C. albicans (ATCC 
10261) 
BM2 32 128 3.07 x 10-17 
SDS 400 800 0.02 
 CTAB 38.8 x10-5 > 620 x10-5 0.03 






Figure 4.2: Effect of BM2 concentration on growth of test organisms after 24 hr. 
 








































































































4.3 Planktonic microorganisms treated with BM2 and detergent combinations 
The effect of BM2 with various detergents showed various patterns between the combinations. The 
results showed that Tween 20 did not increase the efficacy of BM2 against S. mutans (Fig 4.5), E. 
faecalis (Fig 4.6), S. gordonii (Fig 4.7) or C. albicans (Fig 4.8). At the higher concentration of 
BM2 and Tween 20 combination a white precipitate was noted which gave a higher optical density 
reading in the plate reader.  
Combinations of BM2 with CTAB showed increased efficacy of BM2 against S. mutans, E. 
faecalis, and S. gordonii. However with C.albicans CTAB did not increase the efficacy of BM2 
(Fig 4.12). For S. mutans, CTAB at a concentration of 0.25 μg/ml, increased the efficacy of BM2 
at 0.25 μg/ml. For BM2 at 0.5 μg/ml a concentration of more than 0.03 μg/ml of CTAB increased 
the efficacy of BM2 against S. mutans planktonic cells (Fig 4.9). 
For planktonic cells of E. faecalis CTAB at a concentration of more than 0.25 μg/ml, increased the 
efficacy of BM2 at 1 μg/ml and for 2 μg/ml of BM2 the efficacy was increased by more than 0.06 
μg/ml of CTAB (Fig 4.10). For S. gordonii CTAB at a concentration of 0.5 μg/ml, increased the 
efficacy of BM2 at more than 0.06 μg/ml (Fig 4.11). 
There were various patterns portrayed with SDS and BM2 concentrations with the organisms 
tested. At the highest concentration of BM2 and SDS combination a white precipitate was seen in 
the wells, giving a higher optical density reading in the plate reader. S. mutans and E. faecalis 
showed reduction in planktonic cells at different concentrations. SDS increased the efficacy of 
BM2 (0.25 μg/ml) against S. mutans at levels greater than 50 μg/ml and BM2 (0.5 μg/ml) with SDS 
at more than 1.56 μg/ml (Fig 4.13). For E. faecalis SDS at more than 0.625 μg/ml increased the 
efficacy of BM2 (2 μg/ml) and SDS at more than 0.25 μg/ml had a similar effect for of BM2 (1 
μg/ml) (Fig 4.14). S. gordonii showed a dose dependent reduction in the planktonic cells with more 
than 25 μg/ml of SDS and between 0.03-0.25 μg/ml of BM2 (Fig 4.15). SDS did not increase the 






Figure 4.5: Effect of Tween 20 and BM2 on planktonic growth of S. mutans. 
 








































































Figure 4.7: Effect of Tween 20 and BM2 on planktonic growth of S. gordonii. 
 



































































Figure 4.9: Effect of CTAB and BM2 on planktonic growth of S. mutans. 
 









































































Figure 4.11: Effect of CTAB and BM2 on planktonic growth of S. gordonii. 
 





































































Figure 4.13: Effect of SDS and BM2 on planktonic growth of S. mutans. 
 







































































Figure 4.15: Effect of SDS and BM2 on planktonic growth of S. gordonii. 
 





































































4.4 Biofilm disruption with antimicrobials alone 
4.4.1 Biofilm cell density after exposure to BM2 at various time intervals 
Growth of control biofilms for all microorganisms occurred over all time frames tested. The 
addition of BM2 to S. mutans biofilms did not disrupt the biofilms at any concentration tested or 
at any time intervals (Fig. 4.17). The lowest concentration of BM2 that significantly disrupted E. 
faecalis biofilms was 43.5 μg/ml at all time periods (p ≤ 0.05) (Fig.4.18). S. gordonii biofilms were 
disrupted at 174 μg/ml BM2 at the 24 hr and 48 hr time periods (p ≤ 0.05) (Fig. 4.19).While at 72 
hr S. gordonii biofilm was disrupted at 43.5 μg/ml (p ≤ 0.05) (Fig. 4.19). For C. albicans biofilm 
disruption started at 43.5 μg/ml at the 24 hr and 72 hr time periods (p ≤ 0.05). For the 48 hr C. 
albicans biofilm disruption was evident at 43.5 μg/ml and became significantly reduced at 87 μg/ml 








Figure 4.17: S. mutans biofilm cell density after exposure to BM2 at various time intervals. 
 






























S. mutans:  48hrs
































Figure 4.19: S. gordonii biofilm cell density after exposure to BM2 at various time intervals. 
 


































































4.4.2 Biofilm cell density after exposure to CTAB at various time intervals 
The 24 hr S. mutans biofilm absorbance values were significantly reduced at 16 μg/ml CTAB (p ≤ 
0.05) however, at higher concentrations the absorbance values were high. At the 48 hr period high 
absorbance values were recorded. While at the 72 hr period absorbance values showed, a pattern 
consistent of biofilm disruption at all concentrations (p ≤ 0.05) (Fig. 4.21). CTAB did not disrupt 
E. faecalis biofilms at any concentration or time period (Fig. 4.22). Similarly CTAB did not disrupt 
S. gordonii biofilm at any concentrations at 24 hr or 48 hr. The 72 hr S. gordonii biofilm had 
reduced absorbance values for 43.5 μg/ml and 87 μg/ml (p ≤ 0.05), however at higher CTAB 
concentrations the OD reading was high (Fig. 4.23). C. albicans biofilms showed consistent 
disruption,  at 24 hr 174 μg/ml of CTAB gave significant reduction and at the 48 and 72 hr the 








Figure 4.21: S. mutans biofilm cell density after exposure to BM2 at various time intervals. 
 































S. mutans:  48hrs



































Figure 4.23: S. gordonii biofilm cell density after exposure to BM2 at various time intervals. 
 


































































4.4.3 Biofilm cell density after exposure to SDS at various time intervals 
S. mutans biofilms were significantly reduced (p ≤ 0.05) by SDS at 400 μg/ml at all time periods 
(Fig. 4.25). The 24 hr and 48 hr E. faecalis biofilms were significantly reduced (p ≤ 0.05) at 200 
and 400 μg/ml SDS. However at higher SDS concentrations not significant OD readings were 
recorded. The 72 hr E. faecalis biofilm was consistently disrupted at all concentrations tested (p ≤ 
0.05) (Fig. 4.26).  S. gordonii 24 hr biofilms were not disrupted by SDS at any concentration (p > 
0.05). However for the 48 and 72 hr biofilms SDS resulted in significant disruption at all 
concentrations tested (p ≤ 0.05) (Fig. 4.27). C. albicans 24 hr biofilms showed inconsistent 
disruption at SDS concentrations between 400 to 1600 μg/ml however, at 3200 μg/ml there was 










Figure 4.25: S. mutans biofilm cell density after exposure to BM2 at various time intervals. 
 
































S. mutans:  48hrs



































Figure 4.27: S. gordonii biofilm cell density after exposure to BM2 at various time intervals. 
 




































































4.5 Biofilms treated with BM2 and detergent combinations 
4.5.1 Treatment of biofilm with CTAB and BM2 combination after 24 hr  
No combination of CTAB and BM2 disrupted S. mutans, or E. faecalis biofilms. However, at 
higher CTAB and BM2 combinations absorbance readings were higher than the untreated controls 
(Fig. 4.29, Fig. 4.30). For the S. gordonii biofilm there were no significant reductions, however 
there was a trend for reduced biomass at CTAB/BM2 combinations 4 μg/ml /16 μg/ml, 8 μg/ml /8 
μg/ml, and 16 μg/ml /8 μg/ml (Fig. 4.31). Similarly there was a trend for reduced C. albicans 
biofilm mass with combinations of CTAB at 4 and 8 μg/ml and BM2 ranging from 4-16 μg/ml, 













BM2 (μg/ml)   CTAB(μg/ml)   
 0 2 4 8 16 
16 0.2 ± 0.02 0.07 ± 0.00007 0.09 ± 0.00004 0.1 ± 0.0002 0.1 ± 0.0005 
P(T<=t) one-tail 0.3 0.04 0.03 0.02 0.1 
8 0.07 ± 0.00002 0.1 ± 0.0007 0.09 ± 0 0.1 ± 0.00009 0.1 ± 0.0002 
P(T<=t) one-tail 0.3 0.06 0.08 0.04 0.09 
4 0.06 ± 7.9E-06 0.08 ± 0.0001 0.09 ± 4.9E-07 0.09 ± 0.00003 0.1 ± 4.49E-06 
P(T<=t) one-tail 0.2 0.05 0.1 0.03 0.03 
2 0.06 ± 0.00002  0.1 ± 0.004 0.09 ± 0.00003 0.09 ± 0.00003 0.1 ± 4.49E-06 
P(T<=t) one-tail 0.2 0.2 0.06 0.06 0.07 
1 0.06 ± 0.00001 0.08 ± 0.00005  0.08 ± 5.0E-07 0.08 ± 0.00004 0.1 ± 7.9E-06 
P(T<=t) one-tail 0.2 0.06 0.2 0.06 0.08 
0 0.07 ± 0.00009 0.07 ± 7.9E-06 0.07 ± 0.00003 0.07± 0.00004 0.1 ± 0.00003 
P(T<=t) one-tail  0.3 0.4 0.2 0.03 













































BM2 (μg/ml)   CTAB(μg/ml)   
 0 1 2 4 8 
16 0.2 ± 0.0004 0.2 ± 4.50E-06  0.2 ± 0.00004 0.2 ± 0.0005 0.2 ± 0.00004 
P(T<=t) one-tail 0.08 0.009 0.03 0.05 0.002 
8 0.2 ± 0.00001 0.2 ± 0.001 0.2 ± 0.0008 0.2 ± 0.0002 0.2 ± 0.0003 
P(T<=t) one-tail 0.03 0.09 0.05 0.02 0.02 
4 0.15 ± 0.00002 0.2 ± 0.0001 0.2 ± 0.0004 0.2 ± 0.00009 0.2 ± 0.0004 
P(T<=t) one-tail 0.04 0.06 0.05 0.01 0.03 
2 0.1 ± 0.00001 0.1 ± 0.00003 0.1 ± 0.0005 0.1 ± 0.0002 0.2 ± 0.004 
P(T<=t) one-tail 0.05 0.003 0.07 0.06 0.1 
1 0.1 ± 0.00001 0.1 ± 0.00001 0.1± 0.00004 0.1 ± 0.00001 0.2 ± 0.0003 
P(T<=t) one-tail 0.1 0.05 0.01 0.06 0.05 
0 0.1 ± 0.00002 0.09 ± 0.00003 0.09 ± 0.00007 0.09 ± 5.0E-07 0.1 ± 0.0003 
P(T<=t) one-tail  0.5 0.1 0.3 0.2 















































BM2 (μg/ml)   CTAB (μg/ml)  
 0 2 4 8 16 
16 0.9 ± 1.1 0.2 ± 0.005 0.1 ± 0.00001 0.1 ± 0.000002 0.2 ± 0.001 
P(T<=t) one-
tail 
0.3 0.06 0.2 0.2 0.3 




0.3 0.2 0.1 0.2 0.2 
4 0.2 ± 0.0009 0.2 ± 0.00003 0.2 ± 0.00003 0.2 ± 0.0004 0.2 ± 0.00004 
P(T<=t) one-
tail 
0.3 0.2 0.2 0.2 0.2 
2 0.2 ± 0.005 0.2 ± 0.00001 0.2 ± 0.0009 0.2 ± 0.0002 0.2 ± 0.00005 
P(T<=t) one-
tail 
0.3 0.3 0.5 0.2 0.3 




0.1 0.4 0.2 0.4 0.4 
0 0.2 ± 0.007 0.2 ± 0.0001 0.2 ± 0.001 0.1 ± 0.0004 0.1 ± 0.00001 
P(T<=t) one-
tail 
 0.2 0.3 0.2 0.2 


















































  CTAB 
(μg/ml) 
  
 CTAB: 0 CTAB: 2 CTAB: 4 CTAB: 8 CTAB: 16 
BM2:16 0.115 ± 
0.0001 








0.17 0.31 0.27 0.05 0.09 
BM2: 8 0.167 ± 
0.0005 
0.1525 ± 0.005 0.09 ± 0.001 0.078 ± 0.001 0.082 ± 0 
P(T<=t) 
one-tail 
0.38 0.47 0.03 0.19 0.13 
BM2:4 0.246 ± 0.003 0.2495 ± 0.001 0.073 ± 0.001 0.077 ± 0.003 0.16 ± 0.006 
P(T<=t) 
one-tail 
0.02 0.18 0.009 0.01 0.5 
BM2:2 0.25 ± 0.007 0.202 ± 0.001 0.101 ± 0.007 0.2205 
±0.015 
0.1765 ± 0.01 
P(T<=t) 
one-tail 
0.08 0.3 0.13 0.22 0.45 




0.1 0.2 0.3 0.26 0.45 
BM2: 0 0.1595 ± 
0.002 








 0.24 0.12 0.13 0.03 
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4.5.2 Treatment of biofilm with CTAB and BM2 combination after 48 hr  
No combination of CTAB and BM2 disrupted S. mutans, E. faecalis, S. gordonii or C. albicans 
biofilms (Fig. 4.33, Fig. 4.34, Fig. 4.35, Fig. 4.36). At higher CTAB and BM2 combinations the 
absorbance reading was often higher than the untreated control. 
 
BM2 (μg/ml)   CTAB (μg/ml)   
 0 2 4 8 16 
16 0.04 ± 1.9E-06 0.2 ± 0.03 0.2 ± 0.0001 0.2 ± 4.50E-06 0.09 ± 0.003 
P(T<=t) one-tail 0.3 0.2 0.02 0.008 0.2 
8 0.07 ± 0.001 0.2 ± 0.0007 0.09 ± 0.00002 0.09 ± 0.0003 0.1 ± 0.007 
P(T<=t) one-tail 0.2 0.04 0.009 0.07 0.2 
4 0.05 ± 0.0002 0.2 ± 0.0006 0.09 ± 0.0001 0.1 ± 0.001  0.1 ± 0.004 
P(T<=t) one-tail 0.2 0.04 0.06 0.1 0.2 
2 0.04 ± 4.49E-06 0.1 ± 0.002 0.08 ± 0.0007 0.05 ± 0.0001 0.04 ± 0.00003 
P(T<=t) one-tail 0.2 0.1 0.2 0.2 0.25 
1 0.05 ± 0.00005 0.2 ± 0.003 0.09 ± 0.0001 0.04 ± 0.00002 0.04 ± 0.00003 
P(T<=t) one-tail 0.2 0.09 0.04 0.25 0.4 
0 0.04 ± 4.49E-06 0.05 ± 0.00005 0.06 ± 0.0002 0.04 ± 5.0E-07 0.04 ± 0.00003 
P(T<=t) one-tail  0.2 0.1 0.4 0.25 














































BM2 (μg/ml)   CTAB (μg/ml)  
 0 1 2 4 8 
16 0.4 ± 0.02 0.5 ± 0.001 0.6 ± 0.003 0.6 ± 0.09 0.4 ± 0.02 
P(T<=t) one-tail 0.5 0.4 0.3 0.4 0.4 
8 0.4 ± 0.002 0.6 ± 0.03 0.4 ± 0.004 0.5 ± 0.004 0.5 ± 0.001 
P(T<=t) one-tail 0.5 0.3 0.5 0.4 0.4 
4 0.3 ± 0.0003 0.4 ± 0.00001 0.4 ± 0.0009 0.3 ± 0.0005 0.4 ± 5.0E-07 
P(T<=t) one-tail 0.4 0.4 0.5 0.4 0.4 
2 0.3 ± 0.0003 0.3 ± 8.0E-06 0.4 ± 0.00004 0.4 ± 0.001 0.3 ± 0.005 
P(T<=t) one-tail 0.3 0.4 0.4 0.5 0.4 
1 0.2 ± 0.0004 0.3 ± 0.0002 0.3 ± 0.0003 0.4 ± 0.00002 0.4 ± 0.03 
P(T<=t) one-tail 0.3 0.4 0.4 0.5 0.5 
0 0.4 ± 0.07 0.2 ± 0.0002 0.2 ± 0.0002 0.2 ± 0.003 0.4 ± 0.01 
P(T<=t) one-tail  0.3 0.25 0.3 0.4 
















































BM2 (μg/ml)   CTAB (μg/ml)   
 0 2 4 8 16 
16 0.6 ± 0.01 0.6 ± 0.02 0.8 ± 0.03 0.7 ± 0.001 0.8 ± 0.1 
P(T<=t) one-
tail 
0.4 0.5 0.4 0.3 0.3 
8 0.6 ± 0.001 0.7 ± 0.001 0.8 ± 0.02 0.9 ± 0.02 1 ± 0.2 
P(T<=t) one-
tail 
0.5 0.4 0.3 0.2 0.2 
4 0.8 ± 0.03 0.9 ± 0.01 1 ± 0.02 1.1 ± 0.004 2 ± 0.0002 
P(T<=t) one-
tail 
0.3 0.04 0.2 0.1 0.02 
2 0.6 ± 0.0005 0.7 ± 0.007 0.9 ± 8.0E-06 1 ± 0.01 1.5 ± 0.2 
P(T<=t) one-
tail 
0.4 0.4 0.2 0.2 0.09 
1 1 ± 0.06 0.9 ± 0.03 1.4 ± 0.07 1.7 ± 0.002 1.7 ± 0.6 
P(T<=t) one-
tail 
0.2 0.3 0.04 0.05 0.1 
0 0.7 ± 0.005 0.6 ± 0.05 1 ± 0.04 0.8 ± 0.01 1.3 ± 1 
P(T<=t) one-
tail 
 0.4 0.02 0.3 0.2 

















































  CTAB(μg/ml)   
 CTAB: 0 CTAB: 2 CTAB: 4 CTAB: 8 CTAB: 16 
BM2:16 0.137 ± .003 0.097 ± 0.00009 0.0905 ± 
0.0004 




0.16 0.17 0.229 0.21 0.31 
BM2: 8 0.175 ± 2E-
04 








0.04 0.085 0.04 0.08 0.09 
BM2:4 0.149 ± 15E-
04 




0.097 0.17 0.13 0.17 0.19 
BM2:2 0.149 ± 
0.0082 






0.2 0.04 0.05 0.004 0.16 
BM2: 1 0.134 ± 0.008 0.1825 ± 0.04 0.165 ± 0.002 0.182 ± 0.0005 0.16 ± 0.002 
P(T<=t) 
one-tail 
0.1316 0.15 0.13 0.003 0.12 










 0.13 0.15 0.04 0.17 
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4.5.3 Treatment of biofilm with CTAB and BM2 combination after 72 hr  
No combination of CTAB and BM2 disrupted S. mutans, E. faecalis, S. gordonii or C. albicans 
biofilms (Fig. 4.37, Fig. 4.38, Fig. 4.39, and Fig. 4.40). At higher CTAB and BM2 combinations 
the absorbance reading was often higher than the untreated control. 
 
BM2 (μg/ml)   CTAB (μg/ml)   
16 0.05 ± 1.9E-06 0.07 ± 5.0E-07 0.06 ± 0.00002 0.08 ± 0.0001 0.07 ± 0.0004 
P(T<=t) one-tail 0.05 0.02 0.06 0.09 0.2 
8  0.05 ± 0.00003 0.1 ± 0.0002 0.1 ± 0.0004 0.2 ± 0.003 0.1 ± 0.001 
P(T<=t) one-tail 0.2 0.05 0.09 0.1 0.1 
4 0.06 ± 0.00003 0.2 ± 0.0005 0.2 ± 0.0006 0.2 ± 0.0005 0.1 ± 0.006 
P(T<=t) one-tail 0.1 0.04 0.05 0.03 0.2 
2 0.05 ± 0.00001 0.2 ± 0.0002 0.2 ± 0.003 0.2 ± 0.00007 0.2 ± 0.009 
P(T<=t) one-tail 0.2 0.02 0.1 0.009 0.2 
1 0.06 ± 0.00006 0.2 ± 0.00004 0.2 ± 0.0008 0.2 ± 0.0001 0.15 ± 0.01 
P(T<=t) one-tail 0.2 0.009 0.04 0.01 0.2 
0 0.05 ± 5.0E-07 0.05 ± 0.00005 0.05 ± 5.0E-07 0.06 ± 0.0001 0.05 ± 4.50E-
06 
P(T<=t) one-tail  0.2 0.25 0.2 0.2 












































BM2 (μg/ml)   CTAB (μg/ml)   
 0 1 2 4 8 
16 0.6 ± 0.04 0.9 ± 0.1 0.9 ± 0.07 1.03 ± 0.03 0.6 ± 0.008 
P(T<=t) one-
tail 
0.2 0.2 0.08 0.03 0.02 
8 0.7 ± 0.03 0.6 ± 0.001 0.6 ± 0.005 0.7 ± 0.008 0.5 ± 0.001 
P(T<=t) one-
tail 
0.2 0.05 0.05 0.01 0.2 
4 0.5 ± 0.008 0.6 ± 
0.0005 
0.7 ± 0.009 0.7 ± 0.004 0.6 ± 0.02 
P(T<=t) one-
tail 
0.07 0.1 0.02 0.1 0.2 
2 0.4 ± 0.0008 0.5 ± 0.008 0.6 ± 4.50E-06 0.5 ± 0.0006 0.6 ± 0.001 
P(T<=t) one-
tail 
0.4 0.04 0.1 0.2 0.1 
1 0.5 ± 0.03 0.4 ± 0.003 0.5 ± 0.00007 0.5 ± 0.002 0.4 ± 0.005 
P(T<=t) one-
tail 
0.4 0.1 0.2 0.3 0.4 
0 0.4 ± 0.006 0.4 ± 0.006 0.4 ± 0.007 0.4 ± 0.0005 0.5 ± 0.003 
P(T<=t) one-
tail 
 0.007 0.4 0.5 0.3 




















































BM2 (μg/ml)   CTAB (μg/ml)   
 0 2 4 8 16 
16 0.3 ± 0.001 0.3 ± 0.0003 0.3 ± 0.002 0.4 ± 0.007 0.3 ± 0.002 
P(T<=t) one-tail 0.01 0.07 0.03 0.1 0.02 
8 0.2 ± 0.0002 0.2 ± 0.0009 0.3 ± 0.000002 0.4 ± 0 0.4 ± 0.008 
P(T<=t) one-tail 0.09 0.06 0.06 0.03 0.05 
4 0.2 ± 5.0E-07 0.2 ± 0.0001 0.3 ± 0.0002 0.6 ± 0.02 0.4 ± 0.04 
P(T<=t) one-tail 0.2 0.1 0.02 0.07 0.1 
2 0.2 ± 0.00002 0.3 ± 0.0003 0.4 ± 0.0002 0.6 ± 0.06 0.6 ± 0.08 
P(T<=t) one-tail 0.5 0.03 0.04 0.1 0.1 
1 0.1 ± 0.00007 0.3 ± 0.002 0.6 ± 0.05 0.7 ± 0.00002 0.6 ± 0.04 
P(T<=t) one-tail 0.3 0.02 0.1 0.01 0.09 
0 0.2 ± 0.0009 0.2 ± 0.0001 0.2 ± 0.0004 0.3 ± 0.0005 0.4 ± 0.1 
P(T<=t) one-tail  0.09 0.07 0.1 0.2 
























































 CTAB: 0 CTAB: 2 CTAB: 4 CTAB: 8 CTAB: 16 




0.041 ± 0 0.071 ± 0.002 0.08 ± 0.002 
P(T<=t) 
one-tail 
0.23 0.19 0.2 0.4 0.2 
BM2: 8 0.05 ± 
2.45E-05 






0.22 0.4 0.19 0.18 0.25 






0.39 0.32 0.42 0.18 0.1 
BM2:2 0.06 ± 
0.0006 
0.07 ± 0.0006 0.06 ± 
0.0005 
0.06 ± 0.0003  0.08 ± 0.001 
P(T<=t) 
one-tail 
0.4 0.12 0.5 0.5 0.3 










0.5 0.26 0.3 0.39 0.3 
BM2: 0 0.06 ±  
0.0003 




0.1 ± 0.003 
P(T<=t) 
one-tail 
 0.4 0.4 0.4 0.13 
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4.5.4 Treatment of biofilm with SDS and BM2 combination after 24 hr  
The combination of BM2 and SDS at 24hr did not show consistent results with high OD readings 
being associated with higher concentrations of the test materials. There was no combination that 
reduced the S. mutans (Fig. 4.41), E. faecalis (Fig. 4.42) or S. gordonii (Fig. 4.43) biofilms. The 
combinations appeared to have a synergistic effect on C. albicans biofilms with reductions in 
biomass by approximately 50% for some combinations and a significant (p ≤ 0.05) low threshold 















BM2 (μg/ml)   SDS 
(μg/ml) 
  
 0 100 200 400 800 
16 0.05 ± 4.5E-
06 
0.08 ± 0.001 0.06 ±0 0.06 ± 0.0001 0.06 ± 0.00001 
P(T<=t) one-tail 0.25 0.2 0.09 0.2 0.02 
8 0.06 ± 
0.00002 
0.2 ± 0.02 0.1 ± 0.001 0.3 ± 0.0002 0.1 ± 4.49E-06 
P(T<=t) one-tail 0.04 0.2 0.1 0.02 0.002 
4 0.08 ± 0.002 0.2 ± 0.008 0.2 ± 0.0008 0.3 ± 0.01 0.2 ± 0.007 
P(T<=t) one-tail 0.2 0.1 0.06 0.1 0.1 
2 0.09 ± 0.001 0.2 ± 0.009 0.2 ± 0.0001 0.4 ± 0.0008 0.3 ± 0.02 
P(T<=t) one-tail 0.2 0.1 0.02 0.02 0.1 
1 0.07 ± 0.0004 0.2 ± 0.01 0.3 ± 0.01 0.4 ± 4.5E-06 0.2 ± 0.007 
P(T<=t) one-tail 0.1 0.1 0.1 0.003 0.2 






0.1 ± 0.001 0.08 ± 0.0002 
P(T<=t) one-tail  0.2 0.06 0.1 0.1 















































BM2 (μg/ml)   SDS (μg/ml)   
 0 100 200 400 800 
16 0.2 ± 0.0001 0.3 ± 0.001 0.4 ± 0.03 1.08 ± 0.005 0.3 ± 0.007 
P(T<=t) one-
tail 
0.003 0.06 0.1 0.02 0.08 
8 0.2 ± 0.0002 0.3 ± 0.00009 0.3 ± 0.006 0.3 ± 0.01 0.2 ± 0 
P(T<=t) one-
tail 
0.05 0.03 0.08 0.1 0.03 
4 0.2 ± 
0.00004 
0.2 ± 0.0002 0.2 ± 0.00004 0.2 ± 0.00009 0.1 ± 5.0E-07 
P(T<=t) one-
tail 
0.05 0.003 0.04 0.01 0.1 
2 0.1 ± 0.0002 0.2 ± 0.0001 0.2 ± 0.00002 0.1 ± 0.0001 0.1 ± 0.00003 
P(T<=t) one-
tail 
0.1 0.07 0.07 0.2 0.1 
1 0.1 ± 0.0002 0.1 ± 0.00006 0.1 ± 0.0001 0.1 ± 0.00005 0.1 ± 0.0001 
P(T<=t) one-
tail 
0.01 0.02 0.2 0.3 0.3 
0 0.09 ± 
0.0002 
0.1 ± 0.0005 0.1 ± 0.00004 0.09 ± 
0.00002 
0.1 ± 0.00007 
P(T<=t) one-
tail 
 0.06 0.4 0.4 0.4 

















































BM2 (μg/ml)   SDS (μg/ml)   
 0 200 400 800 1600 
16 1.4 ± 0.3 2.6 ± 1 1.7 ± 0.7 0.9 ± 0.0007 0.2 ± 5.0E-07 
P(T<=t) one-
tail 
0.1 0.09 0.2 0.05 0.2 
8 0.5 ± 0.04 1.8 ± 6.4 0.9 ± 0.9 0.4 ± 0.09 0.2 ± 0.0009 
P(T<=t) one-
tail 
0.3 0.3 0.3 0.5 0.09 
4 0.3 ± 
0.00002 
1.2 ± 0.1 0.5 ± 0.0007 0.2 ± 0.0005 0.2 ± 0.006 
P(T<=t) one-
tail 
0.4 0.06 0.1 0.09 0.04 
2 0.4 ± 0.005 1.9 ± 4.1 0.2 ± 4.50E-06 0.2 ± 0.00008 0.3 ± 0.004 
P(T<=t) one-
tail 
0.3 0.3 0.1 0.2 0.08 
1 0.3 ± 0.002 0.3 ± 0.002 0.7 ± 0.5 0.3 ± 0.002 0.2 ± 0.0002 
P(T<=t) one-
tail 
0.3 0.2 0.3 0.4 0.09 
0 0.4 ± 0.001 0.3 ± 0.001 0.2 ± 0.0003 0.2 ± 0.0002 0.1 ± 0.0001 
P(T<=t) one-
tail 
 0.2 0.09 0.1 0.1 





















































  SDS (μg/ml)   
 0 200 400 800 1600 
16 0.1 ± 0.003 0.13 ± 0.0008 0.1 ± 0.0002 0.2 ± 0.007 0.2 ± 0.0005 
P(T<=t) 
one-tail 
0.5 0.3 0.4 0.15 0.2 
8 0.114 ± 0.0006 0.04 ± 0.00001 0.04 ± 7.9E-06 0.05 ± 0 0.09 ± 0.002 
P(T<=t) 
one-tail 
0.25 0.06 0.06 0.05 0.25 
4 0.104  ± 0.005 0.05 ± 8.0E-06 0.07 ± 0.0005 0.07 ± 0.0005 0.1 ± 0.0003 
P(T<=t) 
one-tail 
0.5 0.04 0.05 0.2 0.06 
2 0.05 ± 0.00001 0.05 ± 0.0003 0.1 ± 0.0003 0.05 ± 
0.000002 
0.08 ± 0.0001 
P(T<=t) 
one-tail 
0.06 0.02 0.3 0.05 0.01 
1 0.1 ± 0.02 0.06 ± 0.0002 0.05 ± 0.00002 0.04 ± 0.00002 0.07 ± 0.0001 
P(T<=t) 
one-tail 
0.4 0.1 0.06 0.03 0.005 
0 0.1 ± 0.02 0.06 ± 0.00007 0.05 ± 0.0001 0.06 ± 0.0002 0.09 ± 0.0002 
P(T<=t) 
one-tail 
 0.1 0.1 0.01  
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4.5.5 Treatment of biofilm with SDS and BM2 combination after 48hr  
No combination of SDS and BM2 disrupted S. mutans, E. faecalis or S. gordonii biofilms.  At 
higher SDS and BM2 combinations the absorbance reading was often higher than the untreated 
control (Fig. 4.45, Fig. 4.46, Fig. 4.47). For C. albicans biofilms SDS enhanced the efficacy of 
BM2 when 800 μg/ml of SDS was combined with 4 μg/ml of BM2 (p ≤ 0.05), there were no other 
significant reduction in OD scores. At higher SDS and BM2 combinations the absorbance readings 
















BM2 (μg/ml)   SDS (μg/ml)   
 0 100 200 400 800 
16 0.06 ± 1.9E-06 0.08 ± 0.0002 0.2 ± 0.001 0.09 ± 
0.00005 
0.1 ± 0.002 
P(T<=t) one-
tail 
0.1 0.1 0.07 0.05 0.1 
8 0.06 ± 0.0001 0.1 ± 0.0001 0.1 ± 0.00003 0.09 ± 8.0E-
06 
0.09 ± 0.0007 
P(T<=t) one-
tail 
0.2 0.04 0.01 0.004 0.1 
4 0.07 ± 0.0005 0.1 ± 0.00003 0.1 ± 0.00003 0.1 ± 0.00004 0.08 ± 0.0001 
P(T<=t) one-
tail 
0.2 0.03 0.01 0.03 0.1 
2 0.07 ± 0.0002 0.2 ± 0.0002 0.1 ± 8.0E-06 0.08 ± 
0.00005 
0.06 ± 0.0001 
P(T<=t) one-
tail 
0.1 0.03 0.003 0.06 0.3 








0.4 0.02 0.05 0.2 0.25 












 0.07 0.1 0.5 0.3 
















































BM2 (μg/ml)   SDS (μg/ml)   
 0 100 200 400 800 
16 0.4 ± 0.003 0.6 ± 0.02 1 ± 0.07 1.7 ± 0.03 0.7 ± 0.01 
P(T<=t) one-
tail 
0.05 0.08 0.1 0.02 0.08 
8 0.4 ± 0.006 0.6 ± 0.06 1.1 ± 0.2 1 ± 0.2 0.4 ± 0.003 
P(T<=t) one-
tail 
0.2 0.1 0.07 0.2 0.2 
4 0.4 ± .005 0.6 ± 0.004 1 ± 0.1 0.5 ± 0.03 0.3 ± 0.001 
P(T<=t) one-
tail 
0.1 0.09 0.1 0.2 0.06 
2 0.4 ± 0.0002 0.5 ± 0.004 0.5 ± 0.0002 0.4 ± 0.001 0.4 ± 0.005 
P(T<=t) one-
tail 
0.07 0.04 0.02 0.06 0.2 
1 0.3 ± 0.002 0.6 ± 0.02 0.6 ± 0.004 0.5 ± 0.002 0.3 ± 0.0003 
P(T<=t) one-
tail 
0.1 0.09 0.03 0.1 0.09 
0 0.3 ± 0.0008 0.5 ± 7.9E-06 0.4 ± 0.00005 0.5 ± 0.01 0.4 ± 0.0008 
P(T<=t) one-
tail 
 0.03 0.05 0.2 0.2 















































BM2 (μg/ml)   SDS 
(μg/ml) 
  
 0 200 400 800 1600 
16 1.4 ± 0.3 3 ± 0.00009 3 ± 0.2 3 ± 0.003 1.7 ± 0.00003 
P(T<=t) one-
tail 
0.1 0.03 0.07 0.02 0.07 
8 0.9 ± 0.04 3 ± 0.006 3 ± 0.2 1.3 ± 0.03 1.8 ± 0.02 
P(T<=t) one-
tail 
0.4 0.02 0.06 0.05 0.03 
4 0.9 ± 0.004 1.8 ± 0.3 2.8 ± 0.2 1.4 ± 0.006 1.8 ± 0.2 
P(T<=t) one-
tail 
0.4 0.2 0.02 0.06 0.2 
2 0.9 ± 0.01 1.7 ± 0.2 2.5 ± 0.2 1.3 ± 0.002 2 ± 0.01 
P(T<=t) one-
tail 
0.4 0.2 0.09 0.1 0.06 
1 1 ± 0.003 1.4 ± 0.8 2.7 ± 0.3 1.2 ± 0.02 1.6 ± 0.04 
P(T<=t) one-
tail 
0.2 0.3 0.04 0.2 0.02 
0 0.8 ± 0.005 0.9 ± 0.005 1.2 ± 0.02 2 ± 0.3 1.3 ± 0.3 
P(T<=t) one-
tail 
 0.2 0.08 0.05 0.3 





















































BM2(μg/ml)   SDS (μg/ml)  
 0 200 400 800 1600 
16 0.1 ± 0.0005 0.2 ± 0.00001 0.3 ± 0.002 0.2 ± 0.006 0.2 ± 0.0007 
P(T<=t) one-
tail 
0.09 0.02 0.05 0.1 0.07 
8 0.1 ± 0.0007 0.1 ± 0.0004 0.1 ± 0.02 0.2 ± 0.002 0.1 ± 0.003 
P(T<=t) one-
tail 
0.2 0.1 0.3 0.1 0.1 




0.3  0.09 0.02 0.1 




0.3 0.1 0.2 0.3 0.3 
1 0.09 ± 0.00002 0.1 ± 0.0007 0.08 ± 0.002 0.07 ± 0.0009 0.1 ± 0.0005 
P(T<=t) one-
tail 
0.1 0.2 0.4 0.4 0.07 




0.1 ± 0.0004 
P(T<=t) one-
tail 
 0.07 0.3 0.1 0.02 
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4.5.6 Treatment of biofilm with SDS and BM2 combination after 72 hr  
No combination of SDS and BM2 disrupted S. mutans, S. gordonii or C. albicans biofilms.  At 
higher SDS and BM2 combinations the absorbance reading was often higher than the untreated 
control (Fig. 4.49, Fig. 4.51, Fig. 4.52). Combinations of SDS and BM2 did not consistently disrupt 
E. faecalis biofilm mass, there was a small reduction in absorbance readings at 1 μg/ml BM2 and 
400 and 800 μg/ml SDS (p ≤ 0.05), however greater concentrations resulted in higher absorbance  











BM2 (μg/ml)   SDS (μg/ml)   
 0 100 200 400 800 
16 0.07 ± 0.0002 0.08 ± 5.0E-
07 
0.09 ± 0.00003 0.09 ± 7.9E-
06 
0.08 ± 0.0001 
P(T<=t) one-
tail 
0.2 0.03 0.008 0.05 0.03 
8 0.06 ± 
0.000002 




0.2 0.2 0.02 0.06 0.04 
4 0.07 ± 0.0004 0.1 ± 0.00007 0.1 ± 8.0E-06 0.2 ± 
0.00003 
0.1 ± 0.003 
P(T<=t) one-
tail 
0.2 0.05 0.01 0.02 0.1 
2 0.06 ±0.0002 0.2 ± 0.0001 0.2 ± 0.001 0.2 ± 0.009 0.2 ± 0.007 
P(T<=t) one-
tail 
0.25 0.008 0.08 0.1 0.1 
1 0.05 ± 0.00003 0.1 ± 5.0E-07 0.1 ± 0.0002 0.1 ± 4.50E-
06 
0.2 ± 0.007 
P(T<=t) one-
tail 
0.3 0.03 0.06 0.01 0.2 
0 0.05 ± 0.00004 0.05 ± 0.0002 0.08 ± 0.00003 0.09 ± 5.0E-
07 
0.1 ± 0.0003 
P(T<=t) one-
tail 
 0.4 0.005 0.04 0.05 

















































BM2 (μg/ml)   SDS 
(μg/ml) 
  
 0 100 200 400 800 
16 0.4 ± 0.01 0.8 ± 0.1 0.8 ± 0.0007 1.3 ± 0.001 0.9 ± 0.3 
P(T<=t) one-tail 0.4 0.1 0.005 0.005 0.2 
8 0.5 ± 0.0008 0.8 ± 0.009 2.2 ± 2.8 1.3 ± 0.001 0.7 ± 0.1 
P(T<=t) one-tail 0.06 0.04 0.2 0.005 0.2 
4 0.4 ± 0.00003 0.6 ± 0.02 0.9 ± 0.005 0.9 ± 0.0003 0.4 ± 0.008 
P(T<=t) one-tail 0.06 0.2 0.02 0.0003 0.3 
2 0.3 ± 0.0009 0.5 ± 0.0003 0.5 ± 0.004 0.3 ± 0.001 0.3 ± 0.0001 
P(T<=t) one-tail 0.1 0.05 0.07 0.1 0.07 
1 0.4 ± 0.0003 0.5 ± 0.005 0.5 ± 0.03 0.3 ± 0.0006 0.3 ± 0.0004 
P(T<=t) one-tail 0.1 0.2 0.2 0.03 0.008 
0 0.4 ± 0.0003 0.3 ± 0.00005 0.3 ± 0.0001 0.3 ± 0.001 0.3 ± 0.009 
P(T<=t) one-tail  0.2 0.1 0.06 0.1 

















































BM2 (μg/ml)   SDS (μg/ml)   
 0 200 400 800 1600 
16 1 ± 0.3 1.4 ± 3.8 3.7 ± 0.2 2 ± 0.0001 1.3 ± 0.001 
P(T<=t) one-tail 0.1 0.3 0.03 0.004 0.002 
8 0.3 ± 0.004 2.3 ± 0.8 2.4 ± 0.25 1.2 ± 0.001 1.6 ± 0.04 
P(T<=t) one-tail 0.1 0.1 0.05 0.002 0.04 
4 0.3 ± 0.0005 1.4 ± 0.1 0.9 ± 0.05 1.6 ± 1.1 1.3 ± 0.5 
P(T<=t) one-tail 0.4 0.6 0.06 0.2 0.2 
2 0.3 ± 0.005 0.7 ± 0.006 0.7 ± 0.1 1.5 ± 0.2 1.9 ± 0.002 
P(T<=t) one-tail 0.5 0.06 0.2 0.09 0.01 
1 0.3 ± 0.002 0.5 ± 0.0003 0.4 ± 0.00004 1.2 ± 0.4 0.7 ± 0.1 
P(T<=t) one-tail 0.2 0.01 0.03 0.1 0.2 
0 0.3 ± 0.0007 0.4 ± 0.02 0.7 ± 0.05 1 ± 0.1 1.6 ± 1 
P(T<=t) one-tail  0.2 0.1 0.1 0.2 



















































  SDS (μg/ml)   
 0 200 400 800 1600 
16 0.04 ± 
0.000002 
0.05 ± 0.00004 0.05 ± 0.0003 0.05 ± 0.0003 0.04 ± 1.9E-06 
P(T<=t) 
one-tail 
0.1 0.2 0.2 0.4 0.2 
8 0.05 ± 
0.00001 
0.04 ± 0.00004 0.04 ± 5.01E-07 0.04 ± 4.5E-
06 
0.08 ± 0.001 
P(T<=t) 
one-tail 
0.25 0.2 0.1 0.1 0.2 
4 0.04 ± 0.0001 0.04 ± 
0.000002 
0.04 ± 7.9E-06 0.04 ± 0 0.05 ± 8.0E-06 
P(T<=t) 
one-tail 
0.01 0.1 0.2 0.1 0.2 
2 0.05 ± 0.0001 0.05 ± 0.00006 0.07 ± 0.0007 0.1 ± 0.002 0.1 ± 0.009 
P(T<=t) 
one-tail 
0.3 0.3 0.4 0.1 0.3 
1 0.07 ± 
0.00006 




0.07 0.2 0.1 0.09 0.3 
0 0.06 ± 0.0001 0.05 ± 8.0E-06 0.06 ± 0.001 0.041 ± 
0.000002 
0.05 ± 5.0E-07 
P(T<=t) 
one-tail 
 0.3 0.5 0.2 0.2 














































SDS (μg/ml): 72 hr biofilm
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4.6 Summary of results 
In summary the results of this project (Table 4.2) show that when the test microorganisms are 
planktonic cells, it is easier to kill them with the detergents in isolation or in combination with 
BM2. SDS and CTAB in combination with BM2 increased the efficacy of BM2 against the test 
organisms. Tween 20 did not kill any of the test organisms alone or in combination. 
Biofilms were harder to eradicate as has been shown in numerous work done previously. S. mutans 
biofilm was not disrupted by BM2, however with CTAB and SDS there was disruption of biofilm 
noted at all time periods. Detergents in combination with BM2 did not increase the efficacy of the 
antimicrobial peptide in disrupting S. mutans biofilm. 
E. faecalis biofilm was disrupted by BM2 and SDS, however with CTAB there was no disruption 
of biofilm noted at all time periods. SDS in combination with BM2 did not increase the efficacy of 
the antimicrobial peptide in disrupting E. faecalis biofilm at the 24 and 48 hr periods however at 
the 72 hr period there was disruption of biofilm. CTAB in combination with BM2 did not increase 
the efficacy of the antimicrobial peptide in disrupting E. faecalis biofilm. 
S. gordonii biofilm was disrupted by BM2 at all time periods. However with CTAB there was no 
reduction of biomass noted at the 24 and 48 hr period, but at the 72 hr period there was disruption 
of S. gordonii biofilm. SDS did not show disruption of biofilm at the 24 hr period but at the 48 and 
72 hr periods reduction was noted. CTAB in combination with BM2 increased the efficacy of the 
antimicrobial peptide in disrupting S. gordonii biofilm at the 24 hr period, however at the 48 and 
72 hr no disruption was noted. SDS in combination with BM2 did not increase the efficacy of the 
antimicrobial peptide in disrupting S. gordonii biofilm. 
 C. albicans biofilm was disrupted by BM2, CTAB and SDS at all time periods. CTAB in 
combination with BM2 increased the efficacy of the antimicrobial peptide in disrupting C. albicans 
biofilm at the 24 hr period, however at the 48 and 72 hr no disruption was noted. SDS in 
combination with BM2 increased the efficacy of the antimicrobial peptide in disrupting C. albicans 
biofilm at the 24 and 48 hr periods, however at the 72 hr period, the combination did not disrupt 
C. albicans biofilm. 
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Table 4.2: Summary of results. 













BM2 CTAB SDS 
Micro-
organisms 

























S. mutans  + + + - - - - + - + + + + 
E. faecalis  + + + - + + + - - - + + + 
S. 
gordonii   
 + + + - + + + - - + - + + 
C. 
albicans 
 + + + - + + + + + + + + + 
Combinat
ions 
              
BM2               
S. mutans   + + -    - - - - - - 
E. faecalis   + + -    - - - - - + 
S. 
gordonii   
  + + -    + - - - - - 
C. 
albicans 
  - - -    + - - + + - 
Key 
+    Effective with test organism 




Chapter 5 Discussion 
This study was designed to assess if the addition of a detergent increased the efficacy of the 
antimicrobial peptide BM2 against a chosen group of endodontic microorganisms.  
It was hypothesized that the peptide and detergent combinations would exert an enhanced 
antimicrobial effect on the test microorganisms, and that susceptibility to the combinations would 
vary amongst the different species.  
5.1 Study design and limitations 
In a previous study, susceptibility testing demonstrated the effect of BM2 in planktonic cultures 
and biofilms on a panel of S.mutans, E. faecalis, S. gordonii and C. albicans (Yoganathan 2012). 
The results were based on 98% purity of BM2, however in the present study the commercial 
preparation bought from GenScript (GenScript, New Jersey, USA) at 95% purity when tested 
showed the actual value was approximately 40% the calculated purity of the peptide. This variation 
was taken into account when experiments were conducted, however precise calculations were not 
possible and it was predicted that the MIC and MBC values would not be the same as previous 
work done by the group at Otago. This was confirmed by the results for MIC and MBC, which 
were 2-8 fold higher in comparison to the previous work done by the group (Yoganathan University 
of Otago DClinDent thesis 2012, Othman University of Otago DClinDent thesis 2014).  
Weigand et al. 2008 has highlighted factors like composition of test medium, inoculums size, 
duration, and the presence of resistant subpopulations of microorganisms can influence MIC data 
collected in vitro. In our experiments the MIC results were utilized for the follow-on experiments 
however, we were unable to maintain the volume of the test substance throughout the various 
experiments. 
The major reasons for this had been the concentration of BM2 (in the peptide formulation), the 
volume that could be accommodated in the 96 well plates in the biofilm experiments and the varied 




To compare the antimicrobial preparations’ activity against biofilms a crystal violet assay was used 
as this assay allows for the rapid quantization of antimicrobial activity by measuring a decrease in 
biofilm attachment after exposure to the antimicrobials (Kayaoglu et al. 2005). It was assumed that 
the potency of the antimicrobial would be inversely related to the biomass attachment. However as 
crystal violet binds non-specifically to the chromatin present in cells, regardless of whether a cell 
is viable or dead (Brasaemle & Attie 1988) the results show the estimate of the cells remaining and 
not their viability, hence it can be labeled as a crude measure. However despite being a crude 
measure the crystal violet assay provides a simple method to screen several antimicrobial 
concentrations within a single experiment for their antibiofilm activity (Kayaoglu et al. 2005). 
When performed with three independent tests and in triplicate, the crystal violet assay of biomass 
provided a reproducible data set that enabled inferences about the antimicrobials action on biofilms. 
A better assessment would have been an in situ examination of bacterial cell viability and biofilm 
structure using fluorescent staining (LIVE/DEAD assay) and image analysis. This was planned 
however due to delays in obtaining the BM2 preparation these experiments were not possible 
therefore, it is suggested that this area be explored in the future. 
Most studies on biofilms are based on monospecies biofilms, due to the complexities associated 
with using a multispecies biofilm. The growth of these monospecies biofilms reported in the 
literature is variable with times reported from a couple of hours (Chavez de Paz 2012) to six months 
(Kishen & Haapasalo 2010). The biofilms utilised in the present study were generated in static 
biofilm system grown for 72 hr in 96-well microtitre plates. This system allows handling of 
multiple biofilms monospecies simultaneously, and gives comparative data that does not require 
incubations for long periods of time (Merritt et al. 2005). The study did not look into biofilm aging 
beyond 72 hr of treatment, as the primary aim was to investigate if there was the potential of 
biomass disruption with the antimicrobials used, in combination or separately. The test organisms 
chosen had been species that had been previously tested by the research team and has implications 
in pulp and periapical disease. However the three microorganisms chosen were all gram-positive 
species and addition of gram-negative species would have provided a variety to the results as the 
cell walls are different, however the importance of the species used in biofilm development or 
being directly implicated in endodontic infection indicate their suitability. 
Detergents have a wide range of applications and are regularly used in biochemical laboratories for 
protein molecular weight determination (Shapiro et al. 1967, Weber & Osborn 1969) membrane 
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protein solubilisation, and crystallisation (Garavito & Ferguson-Miller 2001, Privé 2007, Duquesne 
& Sturgis 2010). Hence detergents were chosen as an adjunct to try and investigate if they increase 
the efficacy of BM2. However, despite detergents’ many uses, their interaction with biological 
macromolecules is not very clear. Detergents’ interactions with biomolecules depend on the charge 
on the headgroup, length of the hydrophobic tail, and the nature of the biomolecule under study 
(Tanford 1973). Protein-surfactant interactions have been studied for a long time (Putnam & 
Neurath 1944, Reynolds & Tanford 1970a, 1970b, Jones et al. 1973, Blinkhorn & Jones 1973, 
Jones &  Rumsby 1978, Turro et al. 1995, Wang et al. 1996, Rowshan et al. 1996, Lad et al. 2003, 
Viseu et al. 2004, Tofani et al. 2004, Yamamoto et al. 2004, Moosavi-Movahedi et al. 2005, 
Mikšovská et al. 2006, Chamani et al. 2006, Nielsen et al. 2007, Si-Qing et al. 2007, Andersen et 
al. 2008, 2009, Gangabadage et al. 2008, Schneider et al. 2008, Singh et al. 2008, Moriyama 2008, 
Otzen et al. 2008, Bhuyan 2009, Anand et al. 2010, Otzen 2011, Ryan et al. 2011) and it is well-
known that detergents denature proteins at a concentration almost 1000 times lower than the 
concentration needed for other chemical denaturants such as urea (Turro et al. 1995, Rowshan et 
al. 1996, Wang et al. 1996, Lad et al. 2003, Viseu et al. 2004, Tofani et al. 2004, Mikšovská et al. 
2006, Chamani et al. 2006, Nielsen et al. 2007, Andersen et al. 2008, 2009, Schneider et al. 2008, 
Bhuyan 2009, Anand et al. 2010, Otzen 2011). The assays in this experiment with high 
concentration of detergents caused precipitation in the wells in some cases. This could be caused 
by aggregation by detergents or an aggregation of the peptide BM2 when combined with the 
detergents. To further explore this result, further tests like spectrophotometric analysis, absorbance 
studies and fluorescence studies are required however, this was not possible due to budget and time 
restraints. 
5.2 Antimicrobials activity on planktonic cells 
5.2.1 BM2  
The results of the MIC and MBC determinations substantiated the first hypothesis of the study that 
BM2, CTAB and SDS exert inhibitory and bactericidal actions against the test microorganisms, 
and that differences in susceptibilities varied amongst the strains. It was also hypothesized by us 




BM2 showed potency against the test panel as shown previously (Yoganathan University of Otago 
DClinDent thesis 2012). However the MICs obtained were more than two-fold higher (Table 4.1) 
than the previous studies as spectrophotometric analysis of the peptide obtained showed calculated 
absorbance value was approximately one third the estimated purity of the peptide (Figure 4.2). 
BM2’s efficacy was confirmed and this might be due to its composition of D-amino acids and 
tryptophan residues. Peptides that are at least partially composed of D-amino acids have been 
shown to have strong resistance to proteolysis (Tugyi et al. 2005). BM2 has been proven effective 
against Candida species via the inhibition of the essential plasma membrane proton pump Pma1p 
(Monk et al. 2005). However, its mode of action against bacterial species has yet to be determined. 
The hypothesis for BM2’s mechanism of action against bacteria is that there is a concentration of 
BM2 at bacterial surfaces due to its strong overall positive charge. This would enable ionic 
interaction with the negatively charged surface of bacterial membranes which might interfere with 
local enzyme function or disrupt the membrane (Epand & Vogel 1999). The presence of the 
tryptophan residues in BM2 might have an effect on cell death. Tryptophan has been shown to have 
a high propensity to insert into membranes and to partition near the membrane–water interface 
(Chan et al. 2006) hence resulting in its antimicrobial action. 
5.3 Detergents 
5.3.1 Tween 20 
From the detergents tested polyoxyethylene sorbitan monooleate (Tween 20) (Bio-rad, California, 
USA) failed to inhibit the organisms tested. Tween 20 is quite stable and relatively nontoxic hence, 
its popularity for use as a detergent and emulsifier in a number of domestic, scientific, food industry 
and pharmacological applications. In the food industry one of its uses has been to protect live 
bacterial cells against bile salts toxicity (Noriega et al. 2004, Patel et al. 2004, Li et al. 2011). The 
mechanism of action is via Twee 20 forming different complexes with the salts, therefore inhibiting 
the toxicity to live bacterial cells. Kimoto et al. (2002) reported that the Tween series exhibited 
apparent recovery ability on the growth of Lactococci spp. in the presence of bile salts and its 
ability to enhance the growth of several species of mycobacterium (Stinson & Solotorovsky 1971, 
Cutler et al. 1987, Siddiqi et al. 1988, van-Boxtel et al. 1990).  The growth enhancement is 
proposed to be through alteration of permeability of cell walls therefore facilitating transportation 
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of substrates (Cutler et al. 1987) and through nutrition effect (van-Boxtel et al. 1990). Nutrition is 
provided through mycobacterium hydrolyzing Tween releasing oleic acid which acts as a substrate 
for growth (Stinson & Solotorovsky 1971, Cutler et al. 1987, Siddiqi et al. 1988, van-Boxtel et al. 
1990). There might be similar effects on the microbial panel chosen for this study hence Tween 20 
enhanced the growth of the microorganisms tested. 
5.3.2 CTAB 
Cetyltrimethyl ammonium bromide (CTAB) (Sigma, Thermo Fisher Scientific, Waltham, USA) 
was the most effective at the lowest concentration of substances studied in inhibiting the tested 
organisms (Table 4.1, Fig 4.3). The MIC was 38.8 x 10-5 μg/ml with the test organisms. CTAB’s 
mode of action is attributed to its positive charge (McDonnell & Russell 1999) that appears to 
rupture the cell membrane. The primary site of action of CTAB has been suggested to be the lipid 
components of the membrane, causing cell lysis as a secondary effect (Gilbert et al. 2002) which 
might be the major mechanism of action in the tested microorganisms in this study.  For Candida 
spp. the mechanism of antifungal effect of cationic surfactants and lipids has been shown not to be 
cell lysis but rather the change of cell surface charge from negative to positive (Vieira & Carmona-
Ribeiro 2006). 
5.3.3 SDS 
Sodium dodecyl sulphate (SDS) (Life technologies, Thermo Fisher Scientific, Waltham, USA), 
inhibited growth of the test organisms with MIC values between 200 and 400 μg/ml (Table 4.1, 
Fig 4.4). The most susceptible strains were S. mutans (NG8) and E. faecalis (JH2-2). The least 
susceptible strain was C. albicans (ATCC 10261) and S. gordonii (DL1). Anionic surfactants like 
SDS elicit their strong detergent and biocidal properties, through targeting the outer and 
cytoplasmic membranes and the membrane-bound enzyme functions of cells (Denyer & Stewart 




5.4 Antimicrobials activity on biofilms 
The collation of the results in Table 4.2 showed, behavior of bacterial cells are very different when 
the cells are in suspension to when they are embedded in a biofilm. Conventional treatments that 
are effective against suspended bacteria have been shown to fail against biofilms.  This resistance 
has been attributed to the structure, composition and physiology of the biofilms (Chen & Stewart 
2000, Donlan & Costerton 2002, Gilbert et al. 2002, Fux et al. 2005, Perez-Roa et al. 2006).  
Bacteria living in biofilms have intrinsic mechanisms that protect them from change in 
environmental conditions (exposure to chemical antimicrobials). These mechanisms have not been 
fully researched. However, there are five hypotheses concerning mechanisms by which biofilms 
gain increased resistance to antimicrobial agents: 
 Direct interactions between the biofilm EPS contents and antimicrobials, which might 
affect diffusion and availability;  
 An alteration of the chemical microenvironment within the biofilm leading to areas of less 
or no growth;  
 Through development of biofilm/attachment-specific phenotypes; 
 Through possible damage of bacterial cells via apoptosis or programmed cell death;  
 Through presence of persister cells (Cloete et al. 1998, Lewis 2001, Mah & O’Toole 2001,  
Pereira & Vieira 2001, Spoering & Lewis 2001, Davies 2003, Stewart 2003).  
The persistent cellular state is the latest theory for explaining biofilm insusceptibility to 
antimicrobial agents (Lewis 2001, Sufya et al. 2003). The theory states that the environmental 
conditions under which biofilms are formed have an effect on biofilm phenotype and their 
insusceptibility to conventional control strategies (Simoes et al. 2005a, 2007). Studies have 
reported that turbulent flow generated biofilms had a distinct structure, greater mass, metabolic 
activity and total protein content in when compared to laminar flow generated biofilms (Vieira et 
al. 1993, Pereira et al. 2002, Simoes et al. 2007). Boyle and Lappin-Scott (2006, 2007) have also 
demonstrated that progressive increase in the flow rate from laminar to turbulent had an increased 
effect on the attachment of pseudomonad cells to glass. 
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These studies have reinforced that the behavior of bacterial cells exposed to a toxic environment is 
significantly different when the cells are in suspension or when they are embedded in a biofilm. 
This study has also shown resistance of some of the biofilm microorganisms to disinfection when 
compared with their freely suspended counterparts.  
5.4.1 CTAB 
CTAB is a quaternary ammonium compound with its suggested primary site of action being the 
lipid components of the membrane, causing rupture of the cell membrane (Gilbert et al. 2002). 
These compounds are also lethal to cells by causing protein denaturation, disruption of cell-wall 
permeability and reduction of the normal intake of nutrients (Cloete et al. 1997). 
A study by Simoes et al. (2005) has shown that CTABs ability to inactivate planktonic cells was 
much higher compared to bacteria in biofilms. It also showed that biofilms recovered in terms of 
respiratory activity, in almost all the cases studied, and the application of CTAB by itself did not 
promote the detachment of biofilms. Our study, despite not testing respiratory activity showed 
similar activity of CTAB. When CTAB was exposed to S. mutans biofilm, it showed biofilm 
disruption at the 24 hr and 72 hr periods. However at the 48 hr period, CTAB showed inactivity 
towards S. mutans biofilm. This might be due to biofilm recovery in terms of respiratory activity 
at the 48 hr period however due to significant disruption of the cell membrane CTAB ability to 
disrupt the biofilm was higher at the 72 hr period. 
The results showed quite opposite reaction of the S. mutans biofilm when a combination of CTAB 
and BM2 was applied within the tested time periods. S. mutans biofilm was not affected by the 
combination. This could be explained by Simoes et al. (2005) study that showed CTAB’s 
disinfectant effect being affected by the presence of proteins which promoted the release of ATP 
from the cells. The presence of BM2, a protein, might have affected CTAB activity on the S. mutans 
biofilm similar to the presence of bovine serum albumin (BSA) in Simoes et al. study (2005). 
Ishikawa et al. (2002) showed that surfactants may disturb membrane structure through interaction 
with cellular components, in particular proteins and lipids, therefore they are used to extract 
proteins from cell membranes (Chatterjee et al. 2002). This might be the reason why there was 
diminished antibacterial effect of CTAB in the presence of proteins. The hydrophobic tail of CTAB 
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might have reacted with the hydrophobic core of BM2 and thus the amount of CTAB available for 
reaction with the cells was lower. 
Another reason for the low efficacy of CTAB to control biofilms may be related with its chemical 
reaction with proteins of the exopolymeric matrix as has been shown by Simoes et al. (2005). In 
the present study CTAB was effective with S. mutans planktonic cells, however once exposed to 
biofilms inactivation of CTAB’s activity occurred at 48 hr and when it was combined with BM2 
(more protein) the antibacterial activity halted. The higher inactivation effect on biofilms in the 
presence of BM2 may be due to the higher content of proteins as shown by Simoes et al. (2003a) 
which decreased CTAB’s availability to react with cells.  
E. faecalis biofilm was not disrupted by CTAB at any tested time period, alone or in combination 
with BM2. This might be related to the quality of the biofilm formed or the properties of E. faecalis 
biofilms. E. faecalis is often isolated from persistent apical periodontitis (Sundvist et al. 1998, 
Rôças et al. 2004) and may be harder to remove from root canals due to its ability to invade dentinal 
tubules (Haapasalo & Ørstavik 1987, Love 2001), endure highly alkaline environments (Evans et 
al. 2003, Delgado et al. 2010) and adaptability to adverse conditions found in refractory disease 
(Ørstavik & Haapasalo 1990, Hartke et al. 1998, Love 2001). Additionally, E. faecalis exhibits 
increased resistance to some disinfection regimes (Giard et al. 1996, Laplace et al. 1997) and 
stressed cells up-regulate stress-induced proteins for survival. Love (2004) postulated that E. 
faecalis cells surviving in dentinal tubules might be starved of nutrients and up-regulate stress-
induced proteins for survival. This might explain why E. faecalis biofilms were not killed/disrupted 
by CTAB. The combination of CTAB and BM2 might not have destroyed the biofilm due to BM2 
or CTAB binding to extracellular proteins, e.g. up-regulated stress proteins, rather than to the 
surface of E. faecalis cells.  
S. gordonii biofilm was not affected by CTAB at 24 or 48 hr however at 72 hr CTAB disrupted S. 
gordonii biofilm. This result might be due to CTAB needing time to react to the cell walls of the 
S. gordonii biofilm. When CTAB was combined with BM2, S. gordonii biofilm was disrupted at 
24 hr only. This might be due to the exhaustion of the BM2 and CTAB combination at the 48 hr 
and 72 hr periods. 
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C. albicans biofilm was disrupted very effectively by CTAB at the tested time periods. The 
mechanism of antifungal effect can be explained by Vieira & Carmona-Ribeiro. (2006) study which 
showed, that cationic surfactants and lipids cause cell death by changing the cell surface charge 
from negative to positive. However, when CTAB was combined with BM2 it was fungicidal only 
at the 24 hr period, which might be due to exhaustion of the combination. 
5.4.2 SDS 
The effect of the anionic surfactant sodium dodecyl sulphate (SDS) on the test organism biofilms 
showed that all the organisms tested were disrupted with just S. gordonii biofilm showing 
resistance at the 24 hr period, but from 48 hr exposure to SDS it was disrupted. 
When BM2 was combined with SDS, only C. albicans, at 24 and 48 hr and E. faecalis at 72 hr, 
showed biofilm disruption. The effect on C. albicans biofilm is likely to be due to the fungicidal 
property being exhausted at 48 hr allowing persister cells to re-grow and for E. faecalis the time 
taken for the combination to work might be longer. S. mutans and S. gordonii biofilms were 
unaffected by the combination. The primary reason for this might be the binding of the positively 
charged BM2 with the negatively charged SDS hence exhausting any positive effects that these 
antimicrobials might have. As when applied separately BM2 and SDS on its own affected the test 
biofilms. Also, since the EPS of biofilms is mainly an anionic charged structure (Costerton et al. 
1987), electrostatic repulsion could exist between the anionic EPS and SDS, thus decreasing the 
antimicrobial effect. 
Another explanation might be inferred from Simoes et al. (2008) where low concentrations of SDS 
exposure promoted biofilm cohesion and thus decreased removal, leading to an increase in the 
mechanical stability of the biofilm. They showed that following a temporary reduction effect (in 
terms of respiratory activity), biofilms recovered giving rise to a mechanically stronger biofilm. 
Mechanical stability is an important factor in determining the structure and function of biofilms. 
In engineered systems mechanical stability plays a key role in the removal and/or control of 
biofilms (Mayer et al. 1999, Poppele and Hozalski 2003). Limited studies are available on the 
mechanical stability of biofilms (Ohashi & Harada 1994, 1996, Ohashi et al. 1999, Stoodley et al. 
1999, Korstgens et al. 2001, Poppele & Hozalski 2003, Simoes et al. 2003b, 2005b) and the effect 
of chemical agents on this parameter. 
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Landa et al. (1999) and Marcotte et al. (2004) studied S. mutans biofilms and showed that 
increasing the concentration of SDS promoted an apparent partition of cross-linking electrostatic 
interactions, hence diminishing biofilm cohesiveness. Cross-linking interactions seem to be a 
significant aspect of maintenance of biofilm mechanical stability, as a study on glutaraldehyde, an 
aldehyde based biocide known to cross-link biofilm proteins, increased the mechanical stability of 
P. fluorescens biofilms (Simoes et al. 2003a). 
5.5 Future studies 
The efficacy of BM2 in combination with detergents (especially SDS) in both planktonic cultures 
and biofilms justifies further investigation into their antimicrobial activities, with the view to 
clinical application. 
Research conducted by the team has demonstrated that BM2 has a bactericidal effect on the test 
microorganisms and these include significant endodontic pathogens. Combining detergents to this 
peptide have shown promising results, especially with SDS. However the mode of action against 
the bacterial species tested has not been investigated with the peptide alone or in combination. 
Therefore the mode of action is unknown. Alternative methods could be used to investigate the 
bactericidal properties of these antimicrobials. 
Microscopy could be utilized to detect the morphological changes that AMPs and detergents induce 
on microbial cells. Wang et al. (2012) utilized scanning electron microscopy to demonstrate shape 
loss, cellular debris and pore formation in S. mutans exposed to a novel AMP chrysophsin-1. As 
there are numerous means by which cells get destroyed by detergents and AMPs it is very important 
to know the mode of action, as this would decide if there is synergy or additive effect when the 
antimicrobials are combined. 
Niimi et al. (2004) utilized fluorescent labeling of AMPs and live-cell imaging with confocal 
microscopy in visualizing AMP and fungi interaction. Fungi were used in their experiments as it 
was easier to observe with non-motile and large cell characteristics (Niimi et al. 2004). In another 
study E. coli planktonic cell killing was done using this technique, with time-lapse imaging to 
observe the bactericidal effect of LL-37 (Sochacki et al. 2011). 
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Another method is nuclear magnetic resonance (NMR). This method could be utilised to assess the 
secondary structure of the BM2 and detergents in aqueous solution and its orientation once it 
interacts with the bacterial phospholipid bilayer (Haney et al. 2009). Since studies have shown 
detergents can interact with bacterial cell walls, and BM2s interaction with this wall is not yet 
known, changes after BM2 has been bound could confirm the assertion that BM2 antibacterial 
activity is due to membrane disruption. Preliminary NMR studies indicate that BM2 adopts a turn 
structure in both aqueous solution and in hydrophobic media (Monk, unpublished observations). A 
study by Bahar & Ren (2013) showed extensive plasticity of peptide/detergent–lipid complexes. 
This study opens up the possibility that a peptide induces a certain macromolecular structure when 
interacting with the membranes of one organism, but a different one when interacting with another 
species. This would be a very important experiment, as eliciting what BM2 does to bacteria might 
clarify if there would be any synergy between the combinations. 
Since detergent action on microorganisms is concentration dependent, a key consideration would 
be to find out the tolerance of host tissues to the experimental concentration. Experiments on BM2 
at 54 μM (88 μg/ml) has been shown not to lyse red blood cells and cause only a 20% loss in 
viability of cultured human epithelial (HEp2) cells after 24 hr exposure (Monk et al. 2005). 
However, more tests on mammalian cell lines would be preferred to investigate tolerance of the 
tissues. 
This study has shown biofilm and planktonic cell reduction depending on the type of 
microorganism tested.  It would be interesting to assess if SDS and BM2 combinations would be 
able to penetrate dentinal tubules and hold their substantively within dentine.  
The experiments in this study were carried out against a monospecies biofilm. Future research 
could focus on multispecies biofilms, to portray true endodontic infections that have a complex 
microbial community.  
Our aim was to assess if the combination of detergents might be an effective inter-appointment 
antimicrobial dressing. To confirm this, future experiments on release of SDS and BM2 





The structure, composition and physiology of microbial biofilms have become inexorably linked 
with man’s failure to control them. AMPs have offered a novel solution to biofilm management in 
other fields, and maybe have a future in endodontic biofilm management.  
Within the limits of this in-vitro study, a combination of BM2 and SDS showed antimicrobial 
action against certain endodontic microorganisms occurring as planktonic cells and in biofilms. A 
combination of BM2 and SDS has a potential to be developed into an intracanal medicament for 
clinical management of pulp and periapical disease. Future studies will need to investigate if these 
combinations are stable, non toxic to host tissues and able to retain substantivity within root canal 
systems. Depending on these future study results, a combination of BM2 and SDS can be 
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